<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Rheumatol Int</journal-id><journal-id journal-id-type="iso-abbrev">Rheumatol Int</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Rheumatology International</journal-title></journal-title-group><issn pub-type="ppub">0172-8172</issn><issn pub-type="epub">1437-160X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12204902</article-id><article-id pub-id-type="pmcid-ver">PMC12204902.1</article-id><article-id pub-id-type="pmcaid">12204902</article-id><article-id pub-id-type="pmcaiid">12204902</article-id><article-id pub-id-type="pmid">40576834</article-id><article-id pub-id-type="doi">10.1007/s00296-025-05910-7</article-id><article-id pub-id-type="publisher-id">5910</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Sex- and gender-related differences in systemic lupus erythematosus: a scoping review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0886-0294</contrib-id><name name-style="western"><surname>Albrecht</surname><given-names initials="K">Katinka</given-names></name><address><email>albrecht@drfz.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Troll</surname><given-names initials="W">Wiebke</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3923-2728</contrib-id><name name-style="western"><surname>Callhoff</surname><given-names initials="J">Johanna</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6233-022X</contrib-id><name name-style="western"><surname>Strangfeld</surname><given-names initials="A">Anja</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5943-4688</contrib-id><name name-style="western"><surname>Ohrndorf</surname><given-names initials="S">Sarah</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8915-7837</contrib-id><name name-style="western"><surname>Mucke</surname><given-names initials="J">Johanna</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><aff id="Aff1"><label>1</label>German Rheumatology Research Center Berlin, Program Area Epidemiology and Health Services Research, Berlin, Germany </aff><aff id="Aff2"><label>2</label>Augen&#228;rztliches MVZ Fetscherplatz/Lockwitzgrund Dresden, Dresden, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/001w7jn25</institution-id><institution-id institution-id-type="GRID">grid.6363.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2218 4662</institution-id><institution>Department of Rheumatology and Clinical Immunology, </institution><institution>Charit&#233; Universit&#228;tsmedizin Berlin, </institution></institution-wrap>Berlin, Germany </aff><aff id="Aff4"><label>4</label>Department of Gastroenterology, Hepatology, Infectious Diseases and Rheumatology, Ernst von Bergman Hospital Potsdam, Potsdam, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02xstm723</institution-id><institution>HMU Health and Medical University Potsdam, </institution></institution-wrap>Potsdam, Germany </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024z2rq82</institution-id><institution-id institution-id-type="GRID">grid.411327.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 9917</institution-id><institution>Department of Rheumatology, </institution><institution>University Hospital D&#252;sseldorf, Medical Faculty of Heinrich Heine University, </institution></institution-wrap>D&#252;sseldorf, Germany </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04tsk2644</institution-id><institution-id institution-id-type="GRID">grid.5570.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0490 981X</institution-id><institution>Ruhr Universit&#228;t Bochum, </institution></institution-wrap>Rheumazentrum Ruhrgebiet, Herne, Germany </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>45</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">491708</issue-id><elocation-id>160</elocation-id><history><date date-type="received"><day>5</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>3</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>29</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-29 00:25:28.980"><day>29</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="296_2025_Article_5910.pdf"/><abstract id="Abs1"><p id="Par1">A scoping review was conducted to compile evidence on sex-specific differences in systemic lupus erythematosus (SLE) with focus on autoantibodies, organ manifestation, damage, treatment and patient-reported outcomes (PROs). Systematic searches in PubMed and Cochrane were performed including meta-analyses, observational studies and clinical trials from 01/2015 to 11/2024. Studies of adults with SLE reporting outcomes by sex were eligible. The research protocol is registered in the Registry for Scoping Reviews (OSF, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://osf.io/gfbs9">https://osf.io/gfbs9</ext-link>). From 373 screened articles, 81 publications were included. Studies comprised differences in autoantibodies (<italic toggle="yes">n</italic>&#8201;=&#8201;13), damage (<italic toggle="yes">n</italic>&#8201;=&#8201;40), organ involvement (<italic toggle="yes">n</italic>&#8201;=&#8201;27), treatment (<italic toggle="yes">n</italic>&#8201;=&#8201;14), and PROs (<italic toggle="yes">n</italic>&#8201;=&#8201;6). Twenty studies compared proportions of outcomes by sex with patient numbers ranging from 98 to 11,943. The female/male ratio was between 4:1 and 11:1. The review found a higher age at onset in men and a higher proportion of positive lupus anticoagulant, nephritis, serositis, antiphospholipid syndrome, greater renal and cardiovascular damage and severe infections. SLE in women more often presented with Ro/SSA autoantibodies, alopecia, photosensitivity, Raynaud, and osteoporosis. Some studies showed more frequent cyclophosphamide and less frequent antimalarials in men. Little evidence indicated more frequent non-adherence with azathioprine and mycophenolate in women. Limited evidence was available for PROs. This review confirms significant sex differences in SLE, with men showing later onset, more severe organ damage, and distinct autoantibody and treatment patterns, while women more often present with Ro/SSA autoantibodies, photosensitivity, and osteoporosis. Evidence on patient-reported outcomes remains limited, highlighting the need for further research to guide sex-specific management.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00296-025-05910-7.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Antirheumatic agents</kwd><kwd>Gender differences</kwd><kwd>Patient-reported outcomes</kwd><kwd>Sex differences</kwd><kwd>Systemic lupus erythematosus</kwd></kwd-group><funding-group><award-group><funding-source><institution>Deutsches Rheuma-Forschungszentrum Berlin (DRFZ) (3438)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Systemic lupus erythematosus (SLE) is an autoimmune inflammatory rheumatic disease affecting mostly women. In all nationalities females predominate with a ratio ranging between 1.2:1 and 15:1 [<xref ref-type="bibr" rid="CR1">1</xref>]. Small numbers for men limit the investigation of sex-related differences in clinical trials but a growing number of cohort studies show different manifestations in women and men.</p><p id="Par3">While most studies indicate a tendency for men to experience more severe disease manifestations and greater organ damage in SLE, some research suggests otherwise. Systematic reviews have been conducted to examine sex differences, primarily focusing on clinical manifestations [<xref ref-type="bibr" rid="CR2">2</xref>&#8211;<xref ref-type="bibr" rid="CR4">4</xref>]. However, beyond these well-studied aspects, there is growing evidence that sex differences also extend to the antibody profile, comorbidities, rarer disease manifestations, and patient-reported outcomes (PROs). Despite their significant implications for disease management, these aspects have not yet been comprehensively summarized.</p><p id="Par4">The objective of this scoping review is to provide a broader perspective on sex differences in SLE by mapping existing research across multiple dimensions. Specifically, we aim to synthesize evidence on differences in autoantibodies, organ manifestations, damage, PROs, and treatment approaches.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par5">A systematic literature research was performed in PubMed and Cochrane. English peer-reviewed publications from 01/2015 to 11/2024 were considered. Eligibility criteria included adults with SLE, systematic reviews, observational studies and clinical trials with &#8805;&#8201;20 men, comparing age at onset, autoantibodies, organ manifestation, damage, PROs, treatment adherence, response, efficacy and safety (Supplementary table <xref rid="MOESM1" ref-type="media">S1</xref>). If results were reported in different publications from the same cohort, the more recent study was selected.</p><sec id="Sec6"><title>Search strategy</title><p id="Par6">The search strategy was developed in several steps to capture available evidence without including an excessive number of non-applicable studies. The ubiquitous occurrence of the terms female and sex in almost every SLE study led us to not search for these terms in the main text. Through repeated testing of different search terms, we finally selected a search strategy with an acceptable number of hits (Supplementary table <xref rid="MOESM1" ref-type="media">S2</xref>). Two reviewers (KA, JM) independently screened titles, abstracts and full-texts according to the pre-defined criteria. Disagreements were resolved by discussion. Additional records were identified through supplementary searches on references and conference abstracts.</p></sec><sec id="Sec22"><title>Data extraction</title><p id="Par7">Study characteristics were extracted by study design, origin, period, number of women and men and ethnicity (Supplementary table <xref rid="MOESM1" ref-type="media">S1</xref>).</p></sec><sec id="Sec23"><title>Statistics</title><p id="Par8">We extracted outcomes as proportions, means, or median values. Odds ratios (OR) were calculated as the percentage of men divided by the percentage of women with the corresponding item being present. To show clinically relevant differences, results with OR&#8201;&#8805;&#8201;1.4 were considered more common in men and OR&#8201;&#8804;&#8201;0.7 more common in women. For mean values, minimal clinically important differences (MCID) were used, considering&#8201;&gt;&#8201;3 points difference for Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) [<xref ref-type="bibr" rid="CR5">5</xref>], &gt; 0.3 for Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index (SDI) [<xref ref-type="bibr" rid="CR6">6</xref>] and &gt;&#8201;2 for European Consensus Lupus Activity Measurement (ECLAM) [<xref ref-type="bibr" rid="CR7">7</xref>] and Physician Global Assessment (PGA) [<xref ref-type="bibr" rid="CR7">7</xref>] between women and men as relevant. We do not report significance in form of p-values as a criterion because these not necessarily reflect clinically meaningful differences [<xref ref-type="bibr" rid="CR8">8</xref>]. Adjusted values were considered, e.g. incidence ratios (IR), OR, hazard ratios (HR) or relative rates (RR).</p><p id="Par9">Extracted data was summarised in narrative and table syntheses. We provide a colored illustration of differences, adapted from Coates et al. [<xref ref-type="bibr" rid="CR9">9</xref>], to present the results of a large number of very different studies in a concise way. Since we only extracted descriptive frequency data and did not use them in the form of a meta-analysis, we did not perform a critical appraisal of the included studies as long as the inclusion criteria were met. The review was conducted following the updated methodological guidance for the conduct of scoping reviews [<xref ref-type="bibr" rid="CR10">10</xref>] and the PRISMA Extension for Scoping Reviews (PRISMA-ScR) [<xref ref-type="bibr" rid="CR11">11</xref>]. The research protocol was registered in the Registry for Scoping Reviews (OSF, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://osf.io/gfbs9">https://osf.io/gfbs9</ext-link>). A patient partner (WT) was involved in all stages of the study.</p></sec></sec><sec id="Sec3"><title>Results</title><p id="Par10">From 373 identified records, 81 full-text articles were included (see flow chart in Supplementary figure <xref rid="MOESM1" ref-type="media">S1</xref>). Differences regarding organ manifestation and damage were most frequently reported. Few studies reported differences in PROs and treatment.</p><sec id="Sec7"><title>Study characteristics</title><p id="Par11">Six meta-analyses, four systematic reviews, 62 observational studies, one post-hoc analysis and three case-control studies were included. Of these, 20 studies compared proportions of outcomes by sex. In these studies, patient numbers ranged from 98 to 11,943, with a female/male ratio between 4:1 and 11:1 (Supplementary table <xref rid="MOESM1" ref-type="media">S3</xref>). Study origin and ethnicity varied across studies. Nine studies reported the mean age at onset in men (range 25&#8201;&#177;&#8201;11 years to 44&#8201;&#177;&#8201;21 years) and women (26&#8201;&#177;&#8201;10 to 36&#8201;&#177;&#8201;15 years). In seven of nine studies, men had a higher age at disease onset between 2 and 11 years. In cohorts comparing early versus late onset, men had a higher proportion of late onset [<xref ref-type="bibr" rid="CR12">12</xref>]. In three cohorts, time to diagnosis was longer in females [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>], in one cohort it was equal [<xref ref-type="bibr" rid="CR16">16</xref>] and in another cohort it was longer in men [<xref ref-type="bibr" rid="CR17">17</xref>]. The other included studies reported sex as a risk factor for a specific outcome or other sex-related differences. They are included in the narrative synthesis.</p></sec><sec id="Sec201"><title>Autoantibodies</title><p id="Par12">One meta-analysis and 12 cohort studies compared the presence of autoantibodies in women and men (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). In 5 of 6 studies, Lupus Anticoagulant (LA) occurred with higher odds in men than women (OR 1.3 to 2.0). Anti-Cardiolipin antibodies were slightly more often present in men (OR between 1.1 and 1.3 and 1.7 in one study). In 6 of 9 studies, anti-Ro/SSA autoantibodies occurred more often in women. The presence of other autoantibodies was not consistently different between the two sexes (proportions see Supplementary table <xref rid="MOESM1" ref-type="media">S4</xref>).</p><p id="Par13">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Sex differences in autoantibodies</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e355" orientation="portrait" xlink:href="296_2025_5910_Tab1_HTML.jpg"/></table-wrap>
</p></sec><sec id="Sec210"><title>Disease activity</title><p id="Par14">Levels of disease activity markers were compared in seven cohort studies and one meta-analysis (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Mean or median SLEDAI values were equal or higher in men compared to women. Modeling long-term outcomes from the Hopkins Lupus cohort showed no significant effect of sex on the change in SLEDAI over time [<xref ref-type="bibr" rid="CR18">18</xref>]. One cohort and a meta-analysis found low C3 values more frequent in men [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Mean ECLAM values were compared in one cohort with higher values in men [<xref ref-type="bibr" rid="CR19">19</xref>] (Supplementary table <xref rid="MOESM1" ref-type="media">S5</xref>).</p><p id="Par15">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Sex differences in disease activity markers</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e388" orientation="portrait" xlink:href="296_2025_5910_Tab2_HTML.jpg"/></table-wrap>
</p></sec><sec id="Sec211"><title>Clinical manifestation</title><p id="Par16">Different outcomes regarding clinical manifestations were reported in three meta-analyses and 14 cohort studies (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>). In six out of six studies, women had alopecia more often than men and in four of five studies, Raynaud was more frequent in women. Two meta-analyses found a higher proportion of photosensitivity in women. A slightly more frequent occurrence in women was also shown with malar rash, whereas nephritis, serositis, venous thrombosis and APS were more frequent in men (Supplementary table <xref rid="MOESM1" ref-type="media">S6</xref>). In a retrospective Chinese cohort, thrombocytopenia was more commonly found in young females [<xref ref-type="bibr" rid="CR20">20</xref>], contrasting the result of the other cohort studies.</p><p id="Par17">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Sex differences in clinical manifestation</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e411" orientation="portrait" xlink:href="296_2025_5910_Tab3_HTML.jpg"/></table-wrap>
</p></sec><sec id="Sec221"><title>Lupus nephritis (LN)</title><p id="Par18">A recent meta-analysis on sex differences in the outcome of LN included 20 studies reporting kidney histopathology [<xref ref-type="bibr" rid="CR2">2</xref>]. The data confirmed results from cohort studies that compared to women, men have a greater risk of diffuse proliferative LN class IV/V, worse renal outcomes and a lower chance of complete remission. A meta-analysis on Asian SLE patients confirmed a greater incidence of renal involvement and thrombocytopenia in men compared to women [<xref ref-type="bibr" rid="CR3">3</xref>]. In a Danish risk calculation study for the development of proteinuria, men with lymphopenia had the highest predicted risk of proteinuria [<xref ref-type="bibr" rid="CR21">21</xref>]. A prediction model for a 10-year risk of LN included male sex as risk factor [<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec222"><title>Serositis</title><p id="Par19">In seven cohort studies and two meta-analyses, serositis was more common in men, but did not reach an OR&#8201;&gt;&#8201;1.4 in all studies. A Spanish case-control study also revealed male sex as risk factor for serositis, but women were at higher risk for recurrent serositis [<xref ref-type="bibr" rid="CR23">23</xref>]. Male sex was an independent significant risk factor for pleuritis, but not for pericarditis in a Chinese cohort study [<xref ref-type="bibr" rid="CR24">24</xref>].</p></sec><sec id="Sec223"><title>Neuropsychiatric involvement</title><p id="Par20">The Systemic Lupus International Collaborating Clinics (SLICC) cohort revealed male sex as a risk factor for neuropsychiatric events [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. The distribution in the other cohort studies is inconsistent regarding the occurrence of psychosis, but with a higher occurrence of seizures in men (supplementary table <xref rid="MOESM1" ref-type="media">S6</xref>).</p></sec><sec id="Sec227"><title>Damage</title><p id="Par21">Damage was assessed very differently, in terms of definition, item selection and methodology. In nine cohorts, the proportion of damage was compared in men and women, showing an overall higher proportion of damage in men (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>). A multivariate analysis from the RELESSER cohort found male sex as a risk factor for refractory disease [<xref ref-type="bibr" rid="CR27">27</xref>]. Data from the CSTAR cohort showed that elderly men with a history of major organ involvement at SLE diagnosis were at the highest risk of severe flares and organ damage [<xref ref-type="bibr" rid="CR28">28</xref>]. An SLR on the SLICC damage index (SDI) found male sex associated with higher SDI scores, also in studies that adjusted for age and disease duration [<xref ref-type="bibr" rid="CR29">29</xref>]. In four more recent cohorts, men had higher SDI values [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR30">30</xref>&#8211;<xref ref-type="bibr" rid="CR32">32</xref>], the other studies showed no relevant difference [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR33">33</xref>&#8211;<xref ref-type="bibr" rid="CR36">36</xref>] (Supplementary table <xref rid="MOESM1" ref-type="media">S7</xref>).</p><p id="Par22">
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Sex differences in organ damage</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e498" orientation="portrait" xlink:href="296_2025_5910_Tab4_HTML.jpg"/></table-wrap>
</p></sec><sec id="Sec229"><title>End stage renal disease (ESRD)</title><p id="Par23">The UK CPRD database and a cohort from Taiwan showed a higher incidence rate of ESRD in men compared to women with SLE. The relative risk compared to the general population was also higher in men [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Hypertension was identified as a more significant risk factor for ESRD in women in the Taiwanese cohort. A meta-analysis including 11 studies on nephritis progression found that in women increased serum uric acid levels were associated with higher risk of LN progression [<xref ref-type="bibr" rid="CR39">39</xref>]. No differences in ERSD between men and women were observed in patients with incident LN using a large US claims database [<xref ref-type="bibr" rid="CR40">40</xref>].</p></sec><sec id="Sec228"><title>Cardiovascular (CV) disease</title><p id="Par24">Male sex was confirmed as risk factor for CV disease in SLE in an umbrella review comprising the results from three systematic reviews [<xref ref-type="bibr" rid="CR41">41</xref>]. A meta-analysis from 2015 including 32 studies identified male sex as a predictor of CV events in SLE (OR 6.2 [1.49-25]) [<xref ref-type="bibr" rid="CR42">42</xref>]. A SLR for coronary heart disease also revealed male sex as risk factor in SLE [<xref ref-type="bibr" rid="CR43">43</xref>]. All recent cohort studies consistently confirm a higher risk of CV damage in men compared to women. Population-based US registry data found the highest rates of CV events in men younger than 50 [<xref ref-type="bibr" rid="CR44">44</xref>]. Male sex was specifically found as independent risk factor for atrial fibrillation, valvular heart disease, aortic aneurysm/dissection and thrombotic events [<xref ref-type="bibr" rid="CR45">45</xref>&#8211;<xref ref-type="bibr" rid="CR48">48</xref>]. Data from a US cohort with hospitalized SLE patients identified that young individuals aged 20&#8211;29 and among them particularly women had the greatest odds of atherosclerotic CV disease compared to sex and age-matched controls [<xref ref-type="bibr" rid="CR49">49</xref>]. A risk prediction model from the CSTAR cohort included male sex as risk factor for CV and cerebral events [<xref ref-type="bibr" rid="CR50">50</xref>].</p></sec><sec id="Sec230"><title>Pulmonary</title><p id="Par25">Male sex was associated with having pulmonary disease identified on chest X-ray in a retrospective cohort [<xref ref-type="bibr" rid="CR51">51</xref>].</p></sec><sec id="Sec240"><title>Autoimmune hemolytic anemia (AIHA)</title><p id="Par26">In a Latin America cohort male sex was a risk factor for severe AIHA (HR 2.26 [1.02&#8211;4.75]) [<xref ref-type="bibr" rid="CR52">52</xref>].</p></sec><sec id="Sec241"><title>Infections</title><p id="Par27">The UK CPRD database showed a higher incidence rate of infections in women with SLE compared to men [<xref ref-type="bibr" rid="CR37">37</xref>]. Within Taiwanese electronic health record-data, male sex was identified as a risk factor for Pneumocystis jirovecii pneumonia (PJP) infection in SLE (HR 2.42 [1.31;4.46]) [<xref ref-type="bibr" rid="CR53">53</xref>]. Male sex was a strong risk factor for COVID-19 [<xref ref-type="bibr" rid="CR54">54</xref>] and COVID-outcomes were found to be more severe in male SLE patients [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Men had a higher risk of tuberculosis in an Indian SLE cohort [<xref ref-type="bibr" rid="CR57">57</xref>]. In a Chinese SLE cohort, latent tuberculosis infection was numerically more frequent in men [<xref ref-type="bibr" rid="CR58">58</xref>].</p></sec><sec id="Sec242"><title>Osseous damage</title><p id="Par28">The UK CPRD database showed a higher absolute risk of osteoporosis in women with SLE compared to men, but the relative risk compared to the general population was higher for men [<xref ref-type="bibr" rid="CR37">37</xref>]. Within Korean claims data, a threefold increased risk of osteoporotic fractures was found in SLE patients compared to non-SLE controls. Male patients had a relatively higher fracture risk [<xref ref-type="bibr" rid="CR59">59</xref>]. In a US-electronic health records analysis, bone mineral density (BMD) was less likely tested in male SLE patients [<xref ref-type="bibr" rid="CR60">60</xref>]. A meta-analysis showed that both female and male SLE patients had a lower BMD at any region (lumbar spine, total hip and femoral neck) than healthy controls [<xref ref-type="bibr" rid="CR61">61</xref>]. Taiwanese claims data showed an increased risk of osteomyelitis in men compared to women with SLE [<xref ref-type="bibr" rid="CR62">62</xref>]. In the longitudinal US Hopkins Lupus cohort, men with SLE had an increased risk for osteonecrosis compared to women [<xref ref-type="bibr" rid="CR63">63</xref>].</p></sec><sec id="Sec244"><title>Malignancies</title><p id="Par29">Within the SLICC cohort and the UK CPRD database, overall cancer risk was related to male sex [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Analyses of Korean claims data and of data from the Spanish RELESSER cohort identified a higher lymphoma risk in men compared to women with SLE [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Regarding hematologic malignancies, the prognosis for men with SLE was poorer in a Chinese case-control study [<xref ref-type="bibr" rid="CR67">67</xref>].</p></sec><sec id="Sec247"><title>PROs</title><p id="Par30"> The review revealed six publications on PROs (Table&#160;<xref rid="Tab5" ref-type="table">5</xref>). Within a large US cohort, men more often lacked confidence in completing medical forms and more frequently required help in reading health-related materials. Moderate to severe pain and fatigue was more frequent in women [<xref ref-type="bibr" rid="CR68">68</xref>]. Differences regarding Quality of Life were assessed within the worldwide Study of Outcomes in Lupus (SOUL) cohort. While men performed worse in the social support domain, women, particularly those in the reproductive age group, assessed worse in cognition and procreation domains with trends for worse functioning on physical health and pain-vitality domains [<xref ref-type="bibr" rid="CR30">30</xref>]. Sex differences in anxiety and depressive symptoms were studied by Macedo et al. They found worse mental health and vitality with more common depressive symptoms and anxiety in women [<xref ref-type="bibr" rid="CR69">69</xref>&#8211;<xref ref-type="bibr" rid="CR71">71</xref>]. Workability was examined in a meta-analysis [<xref ref-type="bibr" rid="CR72">72</xref>]. Only two studies reported sex differences on workability: in a survey from the initial 2000ers, women had a higher risk of work loss [<xref ref-type="bibr" rid="CR73">73</xref>]. In a US cohort study from 2007, men more frequently reported inability to work [<xref ref-type="bibr" rid="CR74">74</xref>] (Supplementary table <xref rid="MOESM1" ref-type="media">S8</xref>).</p><p id="Par31">
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Sex differences in patient-reported outcomes</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e668" orientation="portrait" xlink:href="296_2025_5910_Tab5_HTML.jpg"/></table-wrap>
</p></sec><sec id="Sec250"><title>Treatment</title><p id="Par32">Seven cohort studies reported data on treatment choices in women and men (Table&#160;<xref rid="Tab6" ref-type="table">6</xref>). Cyclophosphamide was applied more frequently in men [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Three cohorts reported a less frequent use of antimalarials in men [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>] and male sex was a negative predictor of filled hydroxychloroquine prescriptions in US Medicare data [<xref ref-type="bibr" rid="CR77">77</xref>]. The frequency of GC use and dosing, either at treatment initiation or over the disease course, reported in seven cohorts, was comparable between women and men [<xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. A modeling from the Hopkins cohort showed no significant effect of sex on the average annual GC dose over time [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par33">
<table-wrap id="Tab6" position="float" orientation="portrait"><label>Table 6</label><caption><p>Differences in proportion of treatments for women and men with SLE</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e726" orientation="portrait" xlink:href="296_2025_5910_Tab6_HTML.jpg"/></table-wrap>
</p><p id="Par34">Adherence to therapy was examined with US claims data, showing higher non-adherence with azathioprine and mycophenolate in women [<xref ref-type="bibr" rid="CR78">78</xref>], but no sex difference in adherence with antimalarials [<xref ref-type="bibr" rid="CR79">79</xref>]. The latter was confirmed in the New Zealand cohort study [<xref ref-type="bibr" rid="CR76">76</xref>].</p><p id="Par35">Regarding safety, the infection risk under belimumab, rituximab or non-biologic immunosuppressives was numerically higher for men in the British BILAG-register in an unadjusted model [<xref ref-type="bibr" rid="CR80">80</xref>]. In post hoc data from five belimumab trials, men had a higher risk for neuropsychiatric flares (HR 3.26 [1.51; 7.04]) [<xref ref-type="bibr" rid="CR81">81</xref>]. No study compared treatment response in women and men.</p></sec><sec id="Sec260"><title>Transgender</title><p id="Par36">A scoping review summarised data from seven case reports referring to transgender individuals with SLE [<xref ref-type="bibr" rid="CR82">82</xref>]. All incident SLE cases occurred in transgender women after estrogen therapy, with variable clinical manifestation. Positive ANA titers are described in up to 30% in transgender populations [<xref ref-type="bibr" rid="CR83">83</xref>].</p><p id="Par37">A summary of findings is presented in Table&#160;<xref rid="Tab7" ref-type="table">7</xref>.</p><p id="Par38">
<table-wrap id="Tab7" position="float" orientation="portrait"><label>Table 7</label><caption><p>Summary of findings</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="d33e770" orientation="portrait" xlink:href="296_2025_5910_Tab7_HTML.jpg"/></table-wrap>
</p></sec></sec><sec id="Sec4"><title>Discussion</title><p id="Par39">This review summarizes the evidence on sex- -related differences in SLE. Key findings include a later disease onset in men, a higher occurrence of specific antiphospholipid antibodies, severe organ involvement and greater disease damage in men in contrast to a higher occurrence of positive Anti-Ro/SSA-antibodies, photosensitivity, alopecia and Raynaud in women.</p><p id="Par40">The causes of sex-specific differences in SLE remain complex, involving genetic, hormonal, and epigenetic factors that influence immune system variations between men and women. While these factors explain the female predominance, they do not fully account for differences in disease manifestations. Testosterone has been shown to inhibit dsDNA antibody production and, to a lesser extent, overall antibody production in B cells [<xref ref-type="bibr" rid="CR84">84</xref>]. However, most studies reviewed found no significant differences in dsDNA antibody positivity, with only one study reporting higher prevalence in men. In contrast, women exhibited higher frequencies of anti-Ro/SSA autoantibodies, consistent with the more common occurrence of secondary Sjoegren&#8217;s syndrome [<xref ref-type="bibr" rid="CR85">85</xref>]. This may be linked to estrogen, which promotes plasma cell proliferation and autoantibody production [<xref ref-type="bibr" rid="CR86">86</xref>]. Other antibody types occurred at similar rates.</p><p id="Par41">The predominance of LA and secondary APS in men with SLE remains unclear. APS may occur as a primary condition or as secondary APS linked to SLE, with a more pronounced female predominance in secondary (7:1 female-to-male ratio) compared to primary APS (3.5:1) [<xref ref-type="bibr" rid="CR87">87</xref>]. Notably, men more often exhibit double positivity for LA and anti-cardiolipin antibodies, though single LA positivity is less common [<xref ref-type="bibr" rid="CR88">88</xref>]. Men also show a higher prevalence of CV diseases, likely related to more frequent smoking [<xref ref-type="bibr" rid="CR17">17</xref>], which increases arterial event risks in LA-positive individuals and may also contribute to higher APS manifestation rates. LN in men more likely progresses to ESRD, partially linked to comorbidities like hypertension, dyslipidemia, and diabetes, although these do not explain the higher occurrence of LN itself. Men are more prone to serositis and severe organ-threatening manifestations like LN and neuropsychiatric lupus, and accumulate more disease damage overall. Detection bias has been suggested, with delayed diagnosis in men potentially allowing severe complications to develop [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. However, some studies report shorter diagnosis times in men [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>], challenging this theory. The increased occurrence of serositis has been linked to a single nucleotide polymorphism in the CXCR3 gene, located on the X chromosome, potentially impacting men more significantly [<xref ref-type="bibr" rid="CR90">90</xref>].</p><p id="Par42">Severe complications, such as CV events, ESRD, severe infections, lymphoma, and osseous damage, are more common in men and the mechanisms behind CV complications require further research [<xref ref-type="bibr" rid="CR91">91</xref>]. In women, atypical myocardial infarction symptoms and a higher risk of atherosclerotic CV disease, especially in younger patients [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR92">92</xref>], highlight the need for tight CV risk management in both sexes. Women also frequently experience osteoporosis, warranting regular bone health assessments for all SLE patients. Men with SLE are more prone to severe infections, including during the COVID-19 pandemic, a trend consistent with the general population. Women&#8217;s stronger innate and adaptive immune responses provide better protection against infections but also contribute to increased autoimmunity, while men are generally more vulnerable to severe infections [<xref ref-type="bibr" rid="CR93">93</xref>].</p><p id="Par43">Sexual dysfunction in men with SLE [<xref ref-type="bibr" rid="CR94">94</xref>&#8211;<xref ref-type="bibr" rid="CR96">96</xref>] is another important concern, though it was not included in the reviewed literature due to the lack of comparative data.</p><p id="Par44">Treatments show men more frequently receiving cyclophosphamide, used for severe disease, and less frequent use of antimalarials. Data on sex-specific therapeutic responses are lacking, emphasizing the need for subgroup analyses in RCTs to evaluate treatment efficacy for both sexes. Medication adherence, a known challenge in SLE [<xref ref-type="bibr" rid="CR97">97</xref>], is critical for treatment success. While some evidence suggests lower adherence in women, further research is needed to confirm this finding.</p><p id="Par45">While there is extensive data on clinical differences in SLE, a research gap remains regarding PROs. Initial findings suggest men face greater challenges with social support, while women report higher levels of mental health symptoms. These patterns align with broader gender differences in behavioral, cognitive, and emotional dimensions [<xref ref-type="bibr" rid="CR98">98</xref>]. Men may also feel discomfort discussing a predominantly female-associated disease, limiting their willingness to seek social support. These findings highlight the need to address both clinical and psychosocial aspects of SLE with gender-sensitive care approaches. Understanding how men and women experience and cope with the disease is crucial for providing holistic care tailored to their specific needs.</p><p id="Par46">Some studies evaluated the validity of diagnostic and quality-of-life tools regarding gender. The EULAR/ACR 2019 criteria performed well in diagnosing SLE across genders [<xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR100">100</xref>] similarly to the LupusPro tool, which demonstrated generalizability to both women and men [<xref ref-type="bibr" rid="CR101">101</xref>].</p><sec id="Sec8"><title>Limitations and strengths</title><p id="Par47">This review highlights sex differences in SLE while considering regional and ethnic variations through included studies. While the breadth of examined outcomes may have led to the omission of studies, this likely does not impact the overall findings. The heterogeneity of studies, with a significant female-to-male ratio disparity in SLE poses methodological challenges. Small male sample sizes hinder meaningful sex-based analyses, though large EHR cohorts have improved data availability. This issue is pronounced in RCTs, which rarely stratify outcomes by sex. A recent RCT on mycophenolate acknowledged sex-specific outcomes but lacked sufficient male participants to estimate risks [<xref ref-type="bibr" rid="CR102">102</xref>]. Men comprise 9% of SLE cases but only 7% in RCTs [<xref ref-type="bibr" rid="CR103">103</xref>], underscoring the need for more inclusive studies.</p></sec><sec id="Sec280"><title>Clinical implications</title><p id="Par48">Future recommendations for SLE should emphasize gender-sensitive care. Increasing awareness of SLE in men is crucial for timely diagnosis, along with intensive treatment for renal, cardiovascular, and neuropsychiatric involvement, proactive management of sexual dysfunction, and tailored social support. For women, attention to atypical myocardial infarction symptoms, mental health concerns, and workplace challenges is essential. Screening for osteoporosis and cancer, with a focus on lymphoma in men, should be prioritized for all patients. Ensuring equitable access to antimalarial therapies is critical. Healthcare providers should consider the potential development of SLE in transgender women undergoing hormone replacement therapy. Addressing both clinical and psychosocial aspects will enable more inclusive and personalised care for all patients.</p></sec></sec><sec id="Sec5" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="296_2025_5910_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Sarah Ohrndorf and Johanna Mucke contributed equally to this work.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>KA, WT, JM, JC, AS, and SO contributed to conceptualization. KA and JM screened abstract, titles and fulltexts for study eligibility. KA extracted data and wrote the study protocol. JC verified the extracted data. KA, WT, JM, JC, AS and SO contributed to the formal analysis. KA wrote the original draft. KA and JC contributed to visualisation. JM and SO supervised the study. WT contributed the patient perspective. KA, WT, JC, AS, SO and JM contributed to manuscript review and editing. KA and JC had full access to full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors take full responsibility for the integrity and accuracy of all aspects of the work.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. There was no funding for this study.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The extracted data are available in the supplementary tables.</p></notes><notes><title>Declarations</title><notes id="FPar3" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par49">KA declares no competing interests. WT has received speaker honoraria from GSK, consultant fees from GSK, Roche and Pfizer. JM has received consultant fees from AbbVie, AstraZeneca, BMS, GlaxoSmithKline, Novartis, Lilly, UCB, Ostuka; Speakers fees from AbbVie, AstraZeneca, Bristol Myers Squibb, GSK, Janssen-Cilag, Lilly, Novartis, Otsuka, grants/research support from GlaxoSmithKline, Sanofi Aventis and travel grants from AbbVie. SO has received speakers fee from AbbVie, Alfasigma, Amgen, AstraZeneca, BMS, Johnson&amp;Johnson, Lilly, Novartis, and UCB; consultant fees from Amgen, Johnson&amp;Johnson, Mylan, Novartis and UCB and Grants/research support from GSK and Novartis. AS has received speaker fees from AbbVie, Galapagos/Alfasigma, Janssen, Lilly, Pfizer, Takeda and UCB. JC has received speaker fees from Janssen, Pfizer, Idorsia.</p></notes><notes><title>Ethical approval</title><p id="Par50">The scoping review is based on previously conducted studies and does not contain any new studies with human participants or animals.</p></notes><notes><title>Patient consent for publication</title><p id="Par51">Not required.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rees</surname><given-names>F</given-names></name><name name-style="western"><surname>Doherty</surname><given-names>M</given-names></name><name name-style="western"><surname>Grainge</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Lanyon</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies</article-title><source>Rheumatology (Oxford)</source><year>2017</year><volume>56</volume><issue>11</issue><fpage>1945</fpage><lpage>1961</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kex260</pub-id><pub-id pub-id-type="pmid">28968809</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W (2017) The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 56(11):1945&#8211;1961<pub-id pub-id-type="pmid">28968809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rheumatology/kex260</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmood</surname><given-names>SB</given-names></name><name name-style="western"><surname>Aziz</surname><given-names>M</given-names></name><name name-style="western"><surname>Malepati</surname><given-names>D</given-names></name><etal/></person-group><article-title>Evaluating sex differences in the characteristics and outcomes of lupus nephritis: A systematic review and Meta-Analysis</article-title><source>Glomerular Dis</source><year>2024</year><volume>4</volume><issue>1</issue><fpage>19</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1159/000535981</pub-id><pub-id pub-id-type="pmid">38293588</pub-id><pub-id pub-id-type="pmcid">PMC10827303</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Mahmood SB, Aziz M, Malepati D et al (2024) Evaluating sex differences in the characteristics and outcomes of lupus nephritis: A systematic review and Meta-Analysis. Glomerular Dis 4(1):19&#8211;32<pub-id pub-id-type="pmid">38293588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000535981</pub-id><pub-id pub-id-type="pmcid">PMC10827303</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>MH</given-names></name><name name-style="western"><surname>Koh</surname><given-names>JWH</given-names></name><name name-style="western"><surname>Ng</surname><given-names>CH</given-names></name><etal/></person-group><article-title>A meta-analysis of clinical manifestations in Asian systemic lupus erythematous: the effects of ancestry, ethnicity and gender</article-title><source>Semin Arthritis Rheum</source><year>2022</year><volume>52</volume><fpage>151932</fpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2021.12.004</pub-id><pub-id pub-id-type="pmid">34996626</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Lee MH, Koh JWH, Ng CH et al (2022) A meta-analysis of clinical manifestations in Asian systemic lupus erythematous: the effects of ancestry, ethnicity and gender. Semin Arthritis Rheum 52:151932<pub-id pub-id-type="pmid">34996626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semarthrit.2021.12.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boodhoo</surname><given-names>KD</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>X</given-names></name></person-group><article-title>Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis</article-title><source>Med (Baltim)</source><year>2016</year><volume>95</volume><issue>29</issue><fpage>e4272</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000004272</pub-id><pub-id pub-id-type="pmcid">PMC5265778</pub-id><pub-id pub-id-type="pmid">27442661</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Boodhoo KD, Liu S, Zuo X (2016) Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Med (Baltim) 95(29):e4272<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000004272</pub-id><pub-id pub-id-type="pmcid">PMC5265778</pub-id><pub-id pub-id-type="pmid">27442661</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>CB</given-names></name><name name-style="western"><surname>Liang</surname><given-names>MH</given-names></name><name name-style="western"><surname>Bae</surname><given-names>SC</given-names></name></person-group><article-title>Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity</article-title><source>Arthritis Res Ther</source><year>2016</year><volume>18</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/s13075-015-0906-9</pub-id><pub-id pub-id-type="pmid">26732314</pub-id><pub-id pub-id-type="pmcid">PMC4718037</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Choi CB, Liang MH, Bae SC (2016) Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity. Arthritis Res Ther 18:1<pub-id pub-id-type="pmid">26732314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13075-015-0906-9</pub-id><pub-id pub-id-type="pmcid">PMC4718037</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Mucke J, Kuss O, Brinks R, Schanze S, Schneider M (2021) LUPUS-BEST-treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trial. Lupus Sci Med;8(1)<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/lupus-2021-000516</pub-id><pub-id pub-id-type="pmcid">PMC8268883</pub-id><pub-id pub-id-type="pmid">34253649</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brunner</surname><given-names>HI</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>GC</given-names></name><name name-style="western"><surname>Klein-Gitelman</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus</article-title><source>Arthritis Care Res (Hoboken)</source><year>2010</year><volume>62</volume><issue>7</issue><fpage>950</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1002/acr.20154</pub-id><pub-id pub-id-type="pmid">20589695</pub-id><pub-id pub-id-type="pmcid">PMC2916727</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Brunner HI, Higgins GC, Klein-Gitelman MS et al (2010) Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62(7):950&#8211;959<pub-id pub-id-type="pmid">20589695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.20154</pub-id><pub-id pub-id-type="pmcid">PMC2916727</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nuzzo</surname><given-names>R</given-names></name></person-group><article-title>Scientific method: statistical errors</article-title><source>Nature</source><year>2014</year><volume>506</volume><issue>7487</issue><fpage>150</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1038/506150a</pub-id><pub-id pub-id-type="pmid">24522584</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Nuzzo R (2014) Scientific method: statistical errors. Nature 506(7487):150&#8211;152<pub-id pub-id-type="pmid">24522584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/506150a</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coates</surname><given-names>LC</given-names></name><name name-style="western"><surname>van der Horst-Bruinsma</surname><given-names>IE</given-names></name><name name-style="western"><surname>Lubrano</surname><given-names>E</given-names></name><etal/></person-group><article-title>Sex-Specific differences in patients with psoriatic arthritis: A systematic review</article-title><source>J Rheumatol</source><year>2023</year><volume>50</volume><issue>4</issue><fpage>488</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.3899/jrheum.220386</pub-id><pub-id pub-id-type="pmid">36243418</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Coates LC, van der Horst-Bruinsma IE, Lubrano E et al (2023) Sex-Specific differences in patients with psoriatic arthritis: A systematic review. J Rheumatol 50(4):488&#8211;496<pub-id pub-id-type="pmid">36243418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3899/jrheum.220386</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>MDJ</given-names></name><name name-style="western"><surname>Marnie</surname><given-names>C</given-names></name><name name-style="western"><surname>Tricco</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Updated methodological guidance for the conduct of scoping reviews</article-title><source>JBI Evid Implement</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1097/XEB.0000000000000277</pub-id><pub-id pub-id-type="pmid">33570328</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Peters MDJ, Marnie C, Tricco AC et al (2021) Updated methodological guidance for the conduct of scoping reviews. JBI Evid Implement 19(1):3&#8211;10<pub-id pub-id-type="pmid">33570328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/XEB.0000000000000277</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tricco</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lillie</surname><given-names>E</given-names></name><name name-style="western"><surname>Zarin</surname><given-names>W</given-names></name><etal/></person-group><article-title>PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation</article-title><source>Ann Intern Med</source><year>2018</year><volume>169</volume><issue>7</issue><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.7326/M18-0850</pub-id><pub-id pub-id-type="pmid">30178033</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Tricco AC, Lillie E, Zarin W et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467&#8211;473<pub-id pub-id-type="pmid">30178033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M18-0850</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakurai</surname><given-names>N</given-names></name><name name-style="western"><surname>Yoshimi</surname><given-names>R</given-names></name><name name-style="western"><surname>Yajima</surname><given-names>N</given-names></name><etal/></person-group><article-title>Characteristic features of late-onset systemic lupus erythematosus: an observational study of data from the lupus registry of nationwide institutions</article-title><source>Lupus</source><year>2024</year><volume>33</volume><issue>12</issue><fpage>1306</fpage><lpage>1316</lpage><pub-id pub-id-type="doi">10.1177/09612033241281507</pub-id><pub-id pub-id-type="pmid">39226537</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Sakurai N, Yoshimi R, Yajima N et al (2024) Characteristic features of late-onset systemic lupus erythematosus: an observational study of data from the lupus registry of nationwide institutions. Lupus 33(12):1306&#8211;1316<pub-id pub-id-type="pmid">39226537</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/09612033241281507</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adwan</surname><given-names>MH</given-names></name><name name-style="western"><surname>Qasem</surname><given-names>U</given-names></name><name name-style="western"><surname>Atawnah</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Insights into systemic lupus erythematosus: a retrospective observational study of clinical features, autoantibodies, and gender-related differences</article-title><source>Rheumatol Int</source><year>2024</year><volume>44</volume><issue>7</issue><fpage>1255</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1007/s00296-024-05592-7</pub-id><pub-id pub-id-type="pmid">38717538</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Adwan MH, Qasem U, Atawnah SY et al (2024) Insights into systemic lupus erythematosus: a retrospective observational study of clinical features, autoantibodies, and gender-related differences. Rheumatol Int 44(7):1255&#8211;1263<pub-id pub-id-type="pmid">38717538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00296-024-05592-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz-Grajales</surname><given-names>C</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>LA</given-names></name><name name-style="western"><surname>Alarc&#243;n</surname><given-names>GS</given-names></name><name name-style="western"><surname>Acosta-Reyes</surname><given-names>J</given-names></name></person-group><article-title>Gender differences in disease activity and clinical features in newly diagnosed systemic lupus erythematosus patients</article-title><source>Lupus</source><year>2016</year><volume>25</volume><issue>11</issue><fpage>1217</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.1177/0961203316635286</pub-id><pub-id pub-id-type="pmid">26921269</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Mu&#241;oz-Grajales C, Gonz&#225;lez LA, Alarc&#243;n GS, Acosta-Reyes J (2016) Gender differences in disease activity and clinical features in newly diagnosed systemic lupus erythematosus patients. Lupus 25(11):1217&#8211;1223<pub-id pub-id-type="pmid">26921269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203316635286</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riveros Frutos</surname><given-names>A</given-names></name><name name-style="western"><surname>Casas</surname><given-names>I</given-names></name><name name-style="western"><surname>R&#250;a-Figueroa</surname><given-names>I</given-names></name><etal/></person-group><article-title>Systemic lupus erythematosus in Spanish males: a study of the Spanish rheumatology society lupus registry (RELESSER) cohort</article-title><source>Lupus</source><year>2017</year><volume>26</volume><issue>7</issue><fpage>698</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1177/0961203316673728</pub-id><pub-id pub-id-type="pmid">27799439</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Riveros Frutos A, Casas I, R&#250;a-Figueroa I et al (2017) Systemic lupus erythematosus in Spanish males: a study of the Spanish rheumatology society lupus registry (RELESSER) cohort. Lupus 26(7):698&#8211;706<pub-id pub-id-type="pmid">27799439</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203316673728</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mihailovic</surname><given-names>J</given-names></name><name name-style="western"><surname>Ribi</surname><given-names>C</given-names></name><name name-style="western"><surname>Chizzolini</surname><given-names>C</given-names></name><etal/></person-group><article-title>Worse cardiovascular and renal outcome in male SLE patients</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><issue>1</issue><fpage>18628</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-45171-7</pub-id><pub-id pub-id-type="pmid">37903784</pub-id><pub-id pub-id-type="pmcid">PMC10616173</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Mihailovic J, Ribi C, Chizzolini C et al (2023) Worse cardiovascular and renal outcome in male SLE patients. Sci Rep 13(1):18628<pub-id pub-id-type="pmid">37903784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-45171-7</pub-id><pub-id pub-id-type="pmcid">PMC10616173</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Trentin F, Signorini V, Manca ML et al (2023) Gender differences in SLE: report from a cohort of 417 Caucasian patients. Lupus Sci Med;10(1)<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/lupus-2022-000880</pub-id><pub-id pub-id-type="pmcid">PMC10151995</pub-id><pub-id pub-id-type="pmid">37185240</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watson</surname><given-names>P</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>A</given-names></name><name name-style="western"><surname>Birch</surname><given-names>H</given-names></name><name name-style="western"><surname>Fang</surname><given-names>H</given-names></name><name name-style="western"><surname>Petri</surname><given-names>M</given-names></name></person-group><article-title>An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort</article-title><source>Rheumatology (Oxford)</source><year>2015</year><volume>54</volume><issue>4</issue><fpage>623</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/keu375</pub-id><pub-id pub-id-type="pmid">25234659</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Watson P, Brennan A, Birch H, Fang H, Petri M (2015) An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort. Rheumatology (Oxford) 54(4):623&#8211;632<pub-id pub-id-type="pmid">25234659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rheumatology/keu375</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santamar&#237;a-Alza</surname><given-names>Y</given-names></name><name name-style="western"><surname>Motta</surname><given-names>JZN</given-names></name><name name-style="western"><surname>Fajardo-Rivero</surname><given-names>JE</given-names></name><name name-style="western"><surname>Pineda</surname><given-names>CLF</given-names></name></person-group><article-title>Systemic lupus erythematosus, gender differences in Colombian patients</article-title><source>Clin Rheumatol</source><year>2018</year><volume>37</volume><issue>9</issue><fpage>2423</fpage><lpage>2428</lpage><pub-id pub-id-type="doi">10.1007/s10067-018-4161-8</pub-id><pub-id pub-id-type="pmid">29860566</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Santamar&#237;a-Alza Y, Motta JZN, Fajardo-Rivero JE, Pineda CLF (2018) Systemic lupus erythematosus, gender differences in Colombian patients. Clin Rheumatol 37(9):2423&#8211;2428<pub-id pub-id-type="pmid">29860566</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10067-018-4161-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Ding</surname><given-names>F</given-names></name><name name-style="western"><surname>Shu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus</article-title><source>Med (Baltim)</source><year>2018</year><volume>97</volume><issue>27</issue><fpage>e11356</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000011356</pub-id><pub-id pub-id-type="pmcid">PMC6076144</pub-id><pub-id pub-id-type="pmid">29979417</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Li J, Pan Z, Liu H, Ding F, Shu Q, Li X (2018) Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus. Med (Baltim) 97(27):e11356<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000011356</pub-id><pub-id pub-id-type="pmcid">PMC6076144</pub-id><pub-id pub-id-type="pmid">29979417</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>M</given-names></name><name name-style="western"><surname>Stockmarr</surname><given-names>A</given-names></name><name name-style="western"><surname>Leffers</surname><given-names>HCB</given-names></name><etal/></person-group><article-title>Absolute risk Estimation of new-onset proteinuria in patients with systemic lupus erythematosus: a Danish nationwide cohort study</article-title><source>Clin Exp Rheumatol</source><year>2023</year><volume>41</volume><issue>11</issue><fpage>2264</fpage><lpage>2268</lpage><pub-id pub-id-type="pmid">37382461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.55563/clinexprheumatol/rk2dxp</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Andersen M, Stockmarr A, Leffers HCB et al (2023) Absolute risk Estimation of new-onset proteinuria in patients with systemic lupus erythematosus: a Danish nationwide cohort study. Clin Exp Rheumatol 41(11):2264&#8211;2268<pub-id pub-id-type="pmid">37382461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.55563/clinexprheumatol/rk2dxp</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>SCW</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YF</given-names></name><name name-style="western"><surname>Yap</surname><given-names>DYH</given-names></name><etal/></person-group><article-title>Risk and factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients</article-title><source>Front Immunol</source><year>2023</year><volume>14</volume><fpage>1200732</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2023.1200732</pub-id><pub-id pub-id-type="pmid">37398664</pub-id><pub-id pub-id-type="pmcid">PMC10311203</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Chan SCW, Wang YF, Yap DYH et al (2023) Risk and factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients. Front Immunol 14:1200732<pub-id pub-id-type="pmid">37398664</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2023.1200732</pub-id><pub-id pub-id-type="pmcid">PMC10311203</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gimeno-Torres</surname><given-names>L</given-names></name><name name-style="western"><surname>Carri&#243;n-Barber&#224;</surname><given-names>I</given-names></name><name name-style="western"><surname>Dur&#225;n</surname><given-names>X</given-names></name><name name-style="western"><surname>Villegas</surname><given-names>E</given-names></name><name name-style="western"><surname>Monfort</surname><given-names>J</given-names></name><name name-style="western"><surname>Salman-Monte</surname><given-names>TC</given-names></name></person-group><article-title>Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study</article-title><source>Lupus</source><year>2021</year><volume>30</volume><issue>13</issue><fpage>2095</fpage><lpage>2101</lpage><pub-id pub-id-type="doi">10.1177/09612033211049305</pub-id><pub-id pub-id-type="pmid">34794346</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Gimeno-Torres L, Carri&#243;n-Barber&#224; I, Dur&#225;n X, Villegas E, Monfort J, Salman-Monte TC (2021) Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study. Lupus 30(13):2095&#8211;2101<pub-id pub-id-type="pmid">34794346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/09612033211049305</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Leng</surname><given-names>RX</given-names></name><name name-style="western"><surname>Pan</surname><given-names>HF</given-names></name><name name-style="western"><surname>Ye</surname><given-names>DQ</given-names></name></person-group><article-title>The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study</article-title><source>Rheumatol Int</source><year>2017</year><volume>37</volume><issue>2</issue><fpage>305</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1007/s00296-016-3630-0</pub-id><pub-id pub-id-type="pmid">27999942</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Liang Y, Leng RX, Pan HF, Ye DQ (2017) The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatol Int 37(2):305&#8211;311<pub-id pub-id-type="pmid">27999942</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00296-016-3630-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanly</surname><given-names>JG</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>C</given-names></name><name name-style="western"><surname>Bae</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Neuropsychiatric events in systemic lupus erythematosus: predictors of occurrence and resolution in a longitudinal analysis of an international inception cohort</article-title><source>Arthritis Rheumatol</source><year>2021</year><volume>73</volume><issue>12</issue><fpage>2293</fpage><lpage>2302</lpage><pub-id pub-id-type="doi">10.1002/art.41876</pub-id><pub-id pub-id-type="pmid">34042329</pub-id><pub-id pub-id-type="pmcid">PMC8626529</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Hanly JG, Gordon C, Bae SC et al (2021) Neuropsychiatric events in systemic lupus erythematosus: predictors of occurrence and resolution in a longitudinal analysis of an international inception cohort. Arthritis Rheumatol 73(12):2293&#8211;2302<pub-id pub-id-type="pmid">34042329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/art.41876</pub-id><pub-id pub-id-type="pmcid">PMC8626529</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanly</surname><given-names>JG</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Su</surname><given-names>L</given-names></name><etal/></person-group><article-title>Psychosis in systemic lupus erythematosus: results from an international inception cohort study</article-title><source>Arthritis Rheumatol</source><year>2019</year><volume>71</volume><issue>2</issue><fpage>281</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1002/art.40764</pub-id><pub-id pub-id-type="pmid">30375754</pub-id><pub-id pub-id-type="pmcid">PMC6353684</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Hanly JG, Li Q, Su L et al (2019) Psychosis in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Rheumatol 71(2):281&#8211;289<pub-id pub-id-type="pmid">30375754</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/art.40764</pub-id><pub-id pub-id-type="pmcid">PMC6353684</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pego-Reigosa</surname><given-names>JM</given-names></name><name name-style="western"><surname>R&#250;a-Figueroa</surname><given-names>&#205;</given-names></name><name name-style="western"><surname>L&#243;pez-Longo</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus</article-title><source>Lupus</source><year>2015</year><volume>24</volume><issue>7</issue><fpage>720</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1177/0961203314563818</pub-id><pub-id pub-id-type="pmid">25516473</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Pego-Reigosa JM, R&#250;a-Figueroa &#205;, L&#243;pez-Longo FJ et al (2015) Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus. Lupus 24(7):720&#8211;729<pub-id pub-id-type="pmid">25516473</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203314563818</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>F</given-names></name><etal/></person-group><article-title>Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohort</article-title><source>Med</source><year>2024</year><volume>5</volume><issue>10</issue><fpage>1266</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1016/j.medj.2024.06.005</pub-id><pub-id pub-id-type="pmid">38991598</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Ding Y, Zhou Y, Zhan F et al (2024) Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohort. Med 5(10):1266&#8211;1274e3<pub-id pub-id-type="pmid">38991598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.medj.2024.06.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutton</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Bruce</surname><given-names>IN</given-names></name></person-group><article-title>The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review</article-title><source>Semin Arthritis Rheum</source><year>2013</year><volume>43</volume><issue>3</issue><fpage>352</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2013.05.003</pub-id><pub-id pub-id-type="pmid">23786872</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Sutton EJ, Davidson JE, Bruce IN (2013) The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review. Semin Arthritis Rheum 43(3):352&#8211;361<pub-id pub-id-type="pmid">23786872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semarthrit.2013.05.003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jolly</surname><given-names>M</given-names></name><name name-style="western"><surname>Sequeira</surname><given-names>W</given-names></name><name name-style="western"><surname>Block</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Sex differences in quality of life in patients with systemic lupus erythematosus</article-title><source>Arthritis Care Res (Hoboken)</source><year>2019</year><volume>71</volume><issue>12</issue><fpage>1647</fpage><lpage>1652</lpage><pub-id pub-id-type="doi">10.1002/acr.23588</pub-id><pub-id pub-id-type="pmid">29693320</pub-id><pub-id pub-id-type="pmcid">PMC6202275</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Jolly M, Sequeira W, Block JA et al (2019) Sex differences in quality of life in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 71(12):1647&#8211;1652<pub-id pub-id-type="pmid">29693320</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.23588</pub-id><pub-id pub-id-type="pmcid">PMC6202275</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gergianaki</surname><given-names>I</given-names></name><name name-style="western"><surname>Fanouriakis</surname><given-names>A</given-names></name><name name-style="western"><surname>Repa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of crete, Greece</article-title><source>Ann Rheum Dis</source><year>2017</year><volume>76</volume><issue>12</issue><fpage>1992</fpage><lpage>2000</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2017-211206</pub-id><pub-id pub-id-type="pmid">28780511</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Gergianaki I, Fanouriakis A, Repa A et al (2017) Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of crete, Greece. Ann Rheum Dis 76(12):1992&#8211;2000<pub-id pub-id-type="pmid">28780511</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2017-211206</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taraborelli</surname><given-names>M</given-names></name><name name-style="western"><surname>Leuenberger</surname><given-names>L</given-names></name><name name-style="western"><surname>Lazzaroni</surname><given-names>MG</given-names></name><etal/></person-group><article-title>The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus</article-title><source>Lupus</source><year>2016</year><volume>25</volume><issue>12</issue><fpage>1365</fpage><lpage>1368</lpage><pub-id pub-id-type="doi">10.1177/0961203316637431</pub-id><pub-id pub-id-type="pmid">26945023</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Taraborelli M, Leuenberger L, Lazzaroni MG et al (2016) The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus. Lupus 25(12):1365&#8211;1368<pub-id pub-id-type="pmid">26945023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203316637431</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arkema</surname><given-names>EV</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>M</given-names></name><name name-style="western"><surname>Simard</surname><given-names>JF</given-names></name><name name-style="western"><surname>Sjowall</surname><given-names>C</given-names></name></person-group><article-title>Epidemiology and damage accrual of systemic lupus erythematosus in central sweden: A Single-Center Population-Based cohort study over 14 years from Ostergotland County</article-title><source>ACR Open Rheumatol</source><year>2023</year><volume>5</volume><issue>8</issue><fpage>426</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1002/acr2.11585</pub-id><pub-id pub-id-type="pmid">37469135</pub-id><pub-id pub-id-type="pmcid">PMC10425583</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Arkema EV, Saleh M, Simard JF, Sjowall C (2023) Epidemiology and damage accrual of systemic lupus erythematosus in central sweden: A Single-Center Population-Based cohort study over 14 years from Ostergotland County. ACR Open Rheumatol 5(8):426&#8211;432<pub-id pub-id-type="pmid">37469135</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr2.11585</pub-id><pub-id pub-id-type="pmcid">PMC10425583</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarr</surname><given-names>T</given-names></name><name name-style="western"><surname>Papp</surname><given-names>G</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>N</given-names></name><name name-style="western"><surname>Cser&#233;p</surname><given-names>E</given-names></name><name name-style="western"><surname>Zeher</surname><given-names>M</given-names></name></person-group><article-title>Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus</article-title><source>Clin Rheumatol</source><year>2017</year><volume>36</volume><issue>2</issue><fpage>327</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1007/s10067-016-3492-6</pub-id><pub-id pub-id-type="pmid">27889859</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Tarr T, Papp G, Nagy N, Cser&#233;p E, Zeher M (2017) Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus. Clin Rheumatol 36(2):327&#8211;333<pub-id pub-id-type="pmid">27889859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10067-016-3492-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ram&#237;rez Sep&#250;lveda</surname><given-names>JI</given-names></name><name name-style="western"><surname>Bolin</surname><given-names>K</given-names></name><name name-style="western"><surname>Mofors</surname><given-names>J</given-names></name><etal/></person-group><article-title>Sex differences in clinical presentation of systemic lupus erythematosus</article-title><source>Biol Sex Differ</source><year>2019</year><volume>10</volume><issue>1</issue><fpage>60</fpage><pub-id pub-id-type="doi">10.1186/s13293-019-0274-2</pub-id><pub-id pub-id-type="pmid">31843005</pub-id><pub-id pub-id-type="pmcid">PMC6915972</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Ram&#237;rez Sep&#250;lveda JI, Bolin K, Mofors J et al (2019) Sex differences in clinical presentation of systemic lupus erythematosus. Biol Sex Differ 10(1):60<pub-id pub-id-type="pmid">31843005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13293-019-0274-2</pub-id><pub-id pub-id-type="pmcid">PMC6915972</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gui</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bai</surname><given-names>W</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE treatment and research group (CSTAR) registry XVII</article-title><source>Chin Med J (Engl)</source><year>2022</year><volume>135</volume><issue>18</issue><fpage>2191</fpage><lpage>2199</lpage><pub-id pub-id-type="doi">10.1097/CM9.0000000000002360</pub-id><pub-id pub-id-type="pmid">36525605</pub-id><pub-id pub-id-type="pmcid">PMC9771188</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Gui Y, Bai W, Xu J et al (2022) Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE treatment and research group (CSTAR) registry XVII. Chin Med J (Engl) 135(18):2191&#8211;2199<pub-id pub-id-type="pmid">36525605</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CM9.0000000000002360</pub-id><pub-id pub-id-type="pmcid">PMC9771188</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rees</surname><given-names>F</given-names></name><name name-style="western"><surname>Doherty</surname><given-names>M</given-names></name><name name-style="western"><surname>Grainge</surname><given-names>M</given-names></name><name name-style="western"><surname>Lanyon</surname><given-names>P</given-names></name><name name-style="western"><surname>Davenport</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Burden of comorbidity in systemic lupus erythematosus in the UK, 1999&#8211;2012</article-title><source>Arthritis Care Res (Hoboken)</source><year>2016</year><volume>68</volume><issue>6</issue><fpage>819</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1002/acr.22751</pub-id><pub-id pub-id-type="pmid">26473719</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Rees F, Doherty M, Grainge M, Lanyon P, Davenport G, Zhang W (2016) Burden of comorbidity in systemic lupus erythematosus in the UK, 1999&#8211;2012. Arthritis Care Res (Hoboken) 68(6):819&#8211;827<pub-id pub-id-type="pmid">26473719</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.22751</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>KH</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>CF</given-names></name><name name-style="western"><surname>Chou</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Chiou</surname><given-names>MJ</given-names></name><name name-style="western"><surname>See</surname><given-names>LC</given-names></name></person-group><article-title>Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study</article-title><source>Int J Rheum Dis</source><year>2016</year><volume>19</volume><issue>11</issue><fpage>1175</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.1111/1756-185X.12828</pub-id><pub-id pub-id-type="pmid">26864331</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Yu KH, Kuo CF, Chou IJ, Chiou MJ, See LC (2016) Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study. Int J Rheum Dis 19(11):1175&#8211;1182<pub-id pub-id-type="pmid">26864331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1756-185X.12828</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association between serum uric acid level and systemic lupus erythematosus kidney outcome: an observational study in Southern Chinese population and a meta-analysis</article-title><source>Lupus</source><year>2023</year><volume>32</volume><issue>1</issue><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1177/09612033221140267</pub-id><pub-id pub-id-type="pmid">36396610</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Han Y, Lu X, Xiao S et al (2023) Association between serum uric acid level and systemic lupus erythematosus kidney outcome: an observational study in Southern Chinese population and a meta-analysis. Lupus 32(1):83&#8211;93<pub-id pub-id-type="pmid">36396610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/09612033221140267</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feldman</surname><given-names>CH</given-names></name><name name-style="western"><surname>Broder</surname><given-names>A</given-names></name><name name-style="western"><surname>Guan</surname><given-names>H</given-names></name><name name-style="western"><surname>Yazdany</surname><given-names>J</given-names></name><name name-style="western"><surname>Costenbader</surname><given-names>KH</given-names></name></person-group><article-title>Sex differences in health care utilization, End-Stage renal disease, and mortality among medicaid beneficiaries with incident lupus nephritis</article-title><source>Arthritis Rheumatol</source><year>2018</year><volume>70</volume><issue>3</issue><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1002/art.40392</pub-id><pub-id pub-id-type="pmid">29193893</pub-id><pub-id pub-id-type="pmcid">PMC5826885</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Feldman CH, Broder A, Guan H, Yazdany J, Costenbader KH (2018) Sex differences in health care utilization, End-Stage renal disease, and mortality among medicaid beneficiaries with incident lupus nephritis. Arthritis Rheumatol 70(3):417&#8211;426<pub-id pub-id-type="pmid">29193893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/art.40392</pub-id><pub-id pub-id-type="pmcid">PMC5826885</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katayama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yanai</surname><given-names>R</given-names></name><name name-style="western"><surname>Itaya</surname><given-names>T</given-names></name><name name-style="western"><surname>Nagamine</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tanigawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Miyawaki</surname><given-names>Y</given-names></name></person-group><article-title>Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review</article-title><source>Clin Rheumatol</source><year>2023</year><volume>42</volume><issue>11</issue><fpage>2931</fpage><lpage>2941</lpage><pub-id pub-id-type="doi">10.1007/s10067-023-06608-6</pub-id><pub-id pub-id-type="pmid">37142864</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Katayama Y, Yanai R, Itaya T, Nagamine Y, Tanigawa K, Miyawaki Y (2023) Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review. Clin Rheumatol 42(11):2931&#8211;2941<pub-id pub-id-type="pmid">37142864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10067-023-06608-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballocca</surname><given-names>F</given-names></name><name name-style="western"><surname>D&#8217;Ascenzo</surname><given-names>F</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>C</given-names></name><etal/></person-group><article-title>Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis</article-title><source>Eur J Prev Cardiol</source><year>2015</year><volume>22</volume><issue>11</issue><fpage>1435</fpage><lpage>1441</lpage><pub-id pub-id-type="doi">10.1177/2047487314546826</pub-id><pub-id pub-id-type="pmid">25139772</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Ballocca F, D&#8217;Ascenzo F, Moretti C et al (2015) Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. Eur J Prev Cardiol 22(11):1435&#8211;1441<pub-id pub-id-type="pmid">25139772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2047487314546826</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tselios</surname><given-names>K</given-names></name><name name-style="western"><surname>Sheane</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Gladman</surname><given-names>DD</given-names></name><name name-style="western"><surname>Urowitz</surname><given-names>MB</given-names></name></person-group><article-title>Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: A systematic review</article-title><source>J Rheumatol</source><year>2016</year><volume>43</volume><issue>1</issue><fpage>54</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.3899/jrheum.150460</pub-id><pub-id pub-id-type="pmid">26568591</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Tselios K, Sheane BJ, Gladman DD, Urowitz MB (2016) Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: A systematic review. J Rheumatol 43(1):54&#8211;65<pub-id pub-id-type="pmid">26568591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3899/jrheum.150460</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joyce</surname><given-names>DP</given-names></name><name name-style="western"><surname>Berger</surname><given-names>JS</given-names></name><name name-style="western"><surname>Guttmann</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus</article-title><source>Arthritis Res Ther</source><year>2024</year><volume>26</volume><issue>1</issue><fpage>160</fpage><pub-id pub-id-type="doi">10.1186/s13075-024-03395-6</pub-id><pub-id pub-id-type="pmid">39272198</pub-id><pub-id pub-id-type="pmcid">PMC11401284</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Joyce DP, Berger JS, Guttmann A et al (2024) Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus. Arthritis Res Ther 26(1):160<pub-id pub-id-type="pmid">39272198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13075-024-03395-6</pub-id><pub-id pub-id-type="pmcid">PMC11401284</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnado</surname><given-names>A</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Casey</surname><given-names>C</given-names></name><name name-style="western"><surname>Wheless</surname><given-names>L</given-names></name><name name-style="western"><surname>Denny</surname><given-names>JC</given-names></name><name name-style="western"><surname>Crofford</surname><given-names>LJ</given-names></name></person-group><article-title>Phenome-Wide association studies uncover a novel association of increased atrial fibrillation in male patients with systemic lupus erythematosus</article-title><source>Arthritis Care Res (Hoboken)</source><year>2018</year><volume>70</volume><issue>11</issue><fpage>1630</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1002/acr.23553</pub-id><pub-id pub-id-type="pmid">29481723</pub-id><pub-id pub-id-type="pmcid">PMC6109620</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Barnado A, Carroll RJ, Casey C, Wheless L, Denny JC, Crofford LJ (2018) Phenome-Wide association studies uncover a novel association of increased atrial fibrillation in male patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 70(11):1630&#8211;1636<pub-id pub-id-type="pmid">29481723</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.23553</pub-id><pub-id pub-id-type="pmcid">PMC6109620</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watad</surname><given-names>A</given-names></name><name name-style="western"><surname>Tiosano</surname><given-names>S</given-names></name><name name-style="western"><surname>Grysman</surname><given-names>N</given-names></name><etal/></person-group><article-title>The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis</article-title><source>Eur J Clin Invest</source><year>2017</year><volume>47</volume><issue>5</issue><fpage>366</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1111/eci.12744</pub-id><pub-id pub-id-type="pmid">28295225</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Watad A, Tiosano S, Grysman N et al (2017) The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis. Eur J Clin Invest 47(5):366&#8211;371<pub-id pub-id-type="pmid">28295225</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/eci.12744</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Chang</surname><given-names>YS</given-names></name><name name-style="western"><surname>Liu</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Lai</surname><given-names>CC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WS</given-names></name></person-group><article-title>Incidence and risk analysis of aortic aneurysm and aortic dissection among patients with systemic lupus erythematosus: a nationwide population-based study in Taiwan</article-title><source>Lupus</source><year>2014</year><volume>23</volume><issue>7</issue><fpage>665</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1177/0961203314523868</pub-id><pub-id pub-id-type="pmid">24554710</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Wang SH, Chang YS, Liu CJ, Lai CC, Chen TJ, Chen WS (2014) Incidence and risk analysis of aortic aneurysm and aortic dissection among patients with systemic lupus erythematosus: a nationwide population-based study in Taiwan. Lupus 23(7):665&#8211;671<pub-id pub-id-type="pmid">24554710</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203314523868</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barinotti</surname><given-names>A</given-names></name><name name-style="western"><surname>Radin</surname><given-names>M</given-names></name><name name-style="western"><surname>Cecchi</surname><given-names>I</given-names></name><etal/></person-group><article-title>Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head</article-title><source>Int J Cardiol</source><year>2022</year><volume>363</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2022.06.040</pub-id><pub-id pub-id-type="pmid">35714714</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Barinotti A, Radin M, Cecchi I et al (2022) Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head. Int J Cardiol 363:185&#8211;189<pub-id pub-id-type="pmid">35714714</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijcard.2022.06.040</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>G</given-names></name><name name-style="western"><surname>Smilowitz</surname><given-names>NR</given-names></name><name name-style="western"><surname>Blazer</surname><given-names>A</given-names></name><name name-style="western"><surname>Clancy</surname><given-names>R</given-names></name><name name-style="western"><surname>Buyon</surname><given-names>JP</given-names></name><name name-style="western"><surname>Berger</surname><given-names>JS</given-names></name></person-group><article-title>Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients</article-title><source>Mayo Clin Proc</source><year>2019</year><volume>94</volume><issue>8</issue><fpage>1436</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1016/j.mayocp.2019.01.044</pub-id><pub-id pub-id-type="pmid">31303426</pub-id><pub-id pub-id-type="pmcid">PMC6711365</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Katz G, Smilowitz NR, Blazer A, Clancy R, Buyon JP, Berger JS (2019) Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients. Mayo Clin Proc 94(8):1436&#8211;1443<pub-id pub-id-type="pmid">31303426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mayocp.2019.01.044</pub-id><pub-id pub-id-type="pmcid">PMC6711365</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Huang C, Li Y, Wang Z et al (2024) Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVI. RMD Open;10(3)<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/rmdopen-2024-004425</pub-id><pub-id pub-id-type="pmcid">PMC11418496</pub-id><pub-id pub-id-type="pmid">39313305</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>JS</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Littlejohn</surname><given-names>E</given-names></name></person-group><article-title>Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus</article-title><source>Lupus</source><year>2024</year><volume>33</volume><issue>11</issue><fpage>1242</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1177/09612033241273071</pub-id><pub-id pub-id-type="pmid">39134064</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Johnson JS, Zhang C, Littlejohn E (2024) Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus. Lupus 33(11):1242&#8211;1247<pub-id pub-id-type="pmid">39134064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/09612033241273071</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>LA</given-names></name><name name-style="western"><surname>Alarc&#243;n</surname><given-names>GS</given-names></name><name name-style="western"><surname>Harvey</surname><given-names>GB</given-names></name><etal/></person-group><article-title>Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: data from a multiethnic Latin American cohort</article-title><source>Lupus</source><year>2023</year><volume>32</volume><issue>5</issue><fpage>658</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1177/09612033231163745</pub-id><pub-id pub-id-type="pmid">36916674</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Gonz&#225;lez LA, Alarc&#243;n GS, Harvey GB et al (2023) Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: data from a multiethnic Latin American cohort. Lupus 32(5):658&#8211;667<pub-id pub-id-type="pmid">36916674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/09612033231163745</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>WH</given-names></name><name name-style="western"><surname>Lai</surname><given-names>CC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>YF</given-names></name><etal/></person-group><article-title>Pneumocystis jirovecii pneumonia in systemic lupus erythematosus: A nationwide cohort study in Taiwan</article-title><source>Arthritis Care Res (Hoboken)</source><year>2022</year><volume>74</volume><issue>9</issue><fpage>1444</fpage><lpage>1450</lpage><pub-id pub-id-type="doi">10.1002/acr.24584</pub-id><pub-id pub-id-type="pmid">33645012</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Wang WH, Lai CC, Huang YF et al (2022) Pneumocystis jirovecii pneumonia in systemic lupus erythematosus: A nationwide cohort study in Taiwan. Arthritis Care Res (Hoboken) 74(9):1444&#8211;1450<pub-id pub-id-type="pmid">33645012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.24584</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patil</surname><given-names>A</given-names></name><name name-style="western"><surname>Shobha</surname><given-names>V</given-names></name><name name-style="western"><surname>Shenoy</surname><given-names>P</given-names></name><etal/></person-group><article-title>Risk factors associated with COVID-19 in systemic lupus erythematosus: results from a longitudinal prospective cohort</article-title><source>Lupus</source><year>2023</year><volume>32</volume><issue>4</issue><fpage>560</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1177/09612033231155837</pub-id><pub-id pub-id-type="pmid">36731873</pub-id><pub-id pub-id-type="pmcid">PMC9899665</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Patil A, Shobha V, Shenoy P et al (2023) Risk factors associated with COVID-19 in systemic lupus erythematosus: results from a longitudinal prospective cohort. Lupus 32(4):560&#8211;564<pub-id pub-id-type="pmid">36731873</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/09612033231155837</pub-id><pub-id pub-id-type="pmcid">PMC9899665</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehta</surname><given-names>P</given-names></name><name name-style="western"><surname>Gasparyan</surname><given-names>AY</given-names></name><name name-style="western"><surname>Zimba</surname><given-names>O</given-names></name><name name-style="western"><surname>Kitas</surname><given-names>GD</given-names></name></person-group><article-title>Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management</article-title><source>Clin Rheumatol</source><year>2022</year><volume>41</volume><issue>9</issue><fpage>2893</fpage><lpage>2910</lpage><pub-id pub-id-type="doi">10.1007/s10067-022-06227-7</pub-id><pub-id pub-id-type="pmid">35639259</pub-id><pub-id pub-id-type="pmcid">PMC9152659</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Mehta P, Gasparyan AY, Zimba O, Kitas GD (2022) Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management. Clin Rheumatol 41(9):2893&#8211;2910<pub-id pub-id-type="pmid">35639259</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10067-022-06227-7</pub-id><pub-id pub-id-type="pmcid">PMC9152659</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugarte-Gil</surname><given-names>MF</given-names></name><name name-style="western"><surname>Alarc&#243;n</surname><given-names>GS</given-names></name><name name-style="western"><surname>Izadi</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 global rheumatology alliance</article-title><source>Ann Rheum Dis</source><year>2022</year><volume>81</volume><issue>7</issue><fpage>970</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2021-221636</pub-id><pub-id pub-id-type="pmid">35172961</pub-id><pub-id pub-id-type="pmcid">PMC8882632</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Ugarte-Gil MF, Alarc&#243;n GS, Izadi Z et al (2022) Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 global rheumatology alliance. Ann Rheum Dis 81(7):970&#8211;978<pub-id pub-id-type="pmid">35172961</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2021-221636</pub-id><pub-id pub-id-type="pmcid">PMC8882632</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muhammed</surname><given-names>H</given-names></name><name name-style="western"><surname>Jain</surname><given-names>A</given-names></name><name name-style="western"><surname>Pattanaik</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus</article-title><source>Rheumatol Int</source><year>2021</year><volume>41</volume><issue>12</issue><fpage>2185</fpage><lpage>2193</lpage><pub-id pub-id-type="doi">10.1007/s00296-021-04933-0</pub-id><pub-id pub-id-type="pmid">34191047</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Muhammed H, Jain A, Pattanaik SS et al (2021) Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus. Rheumatol Int 41(12):2185&#8211;2193<pub-id pub-id-type="pmid">34191047</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00296-021-04933-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>N</given-names></name><etal/></person-group><article-title>Latent tuberculosis infection and associated factors in patients with systemic lupus erythematosus: a multicenter, Cross-Sectional study</article-title><source>Microbiol Spectr</source><year>2023</year><volume>11</volume><issue>3</issue><fpage>e0084823</fpage><pub-id pub-id-type="doi">10.1128/spectrum.00848-23</pub-id><pub-id pub-id-type="pmid">37158726</pub-id><pub-id pub-id-type="pmcid">PMC10269486</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Zhang L, Ma Y, Jiang N et al (2023) Latent tuberculosis infection and associated factors in patients with systemic lupus erythematosus: a multicenter, Cross-Sectional study. Microbiol Spectr 11(3):e0084823<pub-id pub-id-type="pmid">37158726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/spectrum.00848-23</pub-id><pub-id pub-id-type="pmcid">PMC10269486</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>CS</given-names></name><name name-style="western"><surname>Han</surname><given-names>KD</given-names></name><name name-style="western"><surname>Jung</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Incidence and risk factors for osteoporotic fractures in patients with systemic lupus erythematosus versus matched controls</article-title><source>Korean J Intern Med</source><year>2021</year><volume>36</volume><issue>1</issue><fpage>154</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.3904/kjim.2018.378</pub-id><pub-id pub-id-type="pmid">31234614</pub-id><pub-id pub-id-type="pmcid">PMC7820659</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Kim CS, Han KD, Jung JH et al (2021) Incidence and risk factors for osteoporotic fractures in patients with systemic lupus erythematosus versus matched controls. Korean J Intern Med 36(1):154&#8211;163<pub-id pub-id-type="pmid">31234614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3904/kjim.2018.378</pub-id><pub-id pub-id-type="pmcid">PMC7820659</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boone</surname><given-names>JB</given-names></name><name name-style="western"><surname>Wheless</surname><given-names>L</given-names></name><name name-style="western"><surname>Camai</surname><given-names>A</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>SB</given-names></name><name name-style="western"><surname>Barnado</surname><given-names>A</given-names></name></person-group><article-title>Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure</article-title><source>Lupus</source><year>2021</year><volume>30</volume><issue>3</issue><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1177/0961203320979735</pub-id><pub-id pub-id-type="pmid">33307984</pub-id><pub-id pub-id-type="pmcid">PMC7933066</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Boone JB, Wheless L, Camai A, Tanner SB, Barnado A (2021) Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure. Lupus 30(3):403&#8211;411<pub-id pub-id-type="pmid">33307984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203320979735</pub-id><pub-id pub-id-type="pmcid">PMC7933066</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendoza-Pinto</surname><given-names>C</given-names></name><name name-style="western"><surname>Rojas-Villarraga</surname><given-names>A</given-names></name><name name-style="western"><surname>Molano-Gonz&#225;lez</surname><given-names>N</given-names></name><etal/></person-group><article-title>Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><issue>6</issue><fpage>e0196113</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0196113</pub-id><pub-id pub-id-type="pmid">29897913</pub-id><pub-id pub-id-type="pmcid">PMC5999233</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Mendoza-Pinto C, Rojas-Villarraga A, Molano-Gonz&#225;lez N et al (2018) Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression. PLoS ONE 13(6):e0196113<pub-id pub-id-type="pmid">29897913</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0196113</pub-id><pub-id pub-id-type="pmcid">PMC5999233</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>YF</given-names></name><name name-style="western"><surname>Chang</surname><given-names>YS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WS</given-names></name><etal/></person-group><article-title>Incidence and risk factors of osteomyelitis in adult and pediatric systemic lupus erythematosus: a nationwide, population-based cohort study</article-title><source>Lupus</source><year>2019</year><volume>28</volume><issue>1</issue><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1177/0961203318811601</pub-id><pub-id pub-id-type="pmid">30458691</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Huang YF, Chang YS, Chen WS et al (2019) Incidence and risk factors of osteomyelitis in adult and pediatric systemic lupus erythematosus: a nationwide, population-based cohort study. Lupus 28(1):19&#8211;26<pub-id pub-id-type="pmid">30458691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203318811601</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kallas</surname><given-names>R</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Petri</surname><given-names>M</given-names></name></person-group><article-title>Predictors of osteonecrosis in systemic lupus erythematosus: A prospective cohort study</article-title><source>Arthritis Care Res (Hoboken)</source><year>2022</year><volume>74</volume><issue>7</issue><fpage>1122</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1002/acr.24541</pub-id><pub-id pub-id-type="pmid">33342072</pub-id><pub-id pub-id-type="pmcid">PMC10725725</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Kallas R, Li J, Petri M (2022) Predictors of osteonecrosis in systemic lupus erythematosus: A prospective cohort study. Arthritis Care Res (Hoboken) 74(7):1122&#8211;1132<pub-id pub-id-type="pmid">33342072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.24541</pub-id><pub-id pub-id-type="pmcid">PMC10725725</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernatsky</surname><given-names>S</given-names></name><name name-style="western"><surname>Ramsey-Goldman</surname><given-names>R</given-names></name><name name-style="western"><surname>Urowitz</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Cancer risk in a large inception systemic lupus erythematosus cohort: effects of demographic characteristics, smoking, and medications</article-title><source>Arthritis Care Res (Hoboken)</source><year>2021</year><volume>73</volume><issue>12</issue><fpage>1789</fpage><lpage>1795</lpage><pub-id pub-id-type="doi">10.1002/acr.24425</pub-id><pub-id pub-id-type="pmid">32813314</pub-id><pub-id pub-id-type="pmcid">PMC7892637</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Bernatsky S, Ramsey-Goldman R, Urowitz MB et al (2021) Cancer risk in a large inception systemic lupus erythematosus cohort: effects of demographic characteristics, smoking, and medications. Arthritis Care Res (Hoboken) 73(12):1789&#8211;1795<pub-id pub-id-type="pmid">32813314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.24425</pub-id><pub-id pub-id-type="pmcid">PMC7892637</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bae</surname><given-names>EH</given-names></name><name name-style="western"><surname>Lim</surname><given-names>SY</given-names></name><name name-style="western"><surname>Han</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea</article-title><source>Lupus</source><year>2019</year><volume>28</volume><issue>3</issue><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1177/0961203319826672</pub-id><pub-id pub-id-type="pmid">30712493</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Bae EH, Lim SY, Han KD et al (2019) Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea. Lupus 28(3):317&#8211;323<pub-id pub-id-type="pmid">30712493</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203319826672</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;n-L&#243;pez</surname><given-names>M</given-names></name><name name-style="western"><surname>Galindo</surname><given-names>M</given-names></name><name name-style="western"><surname>Pego-Reigosa</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study</article-title><source>Rheumatology (Oxford)</source><year>2022</year><volume>62</volume><issue>1</issue><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/keac258</pub-id><pub-id pub-id-type="pmid">35482477</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Mart&#237;n-L&#243;pez M, Galindo M, Pego-Reigosa JM et al (2022) Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study. Rheumatology (Oxford) 62(1):217&#8211;224<pub-id pub-id-type="pmid">35482477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rheumatology/keac258</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><etal/></person-group><article-title>Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis-a case-control study</article-title><source>Arthritis Res Ther</source><year>2022</year><volume>24</volume><issue>1</issue><fpage>5</fpage><pub-id pub-id-type="doi">10.1186/s13075-021-02692-8</pub-id><pub-id pub-id-type="pmid">34980230</pub-id><pub-id pub-id-type="pmcid">PMC8722144</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Zhang Y, Li W, Zhang P et al (2022) Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis-a case-control study. Arthritis Res Ther 24(1):5<pub-id pub-id-type="pmid">34980230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13075-021-02692-8</pub-id><pub-id pub-id-type="pmcid">PMC8722144</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rice</surname><given-names>C</given-names></name><name name-style="western"><surname>Ayyala</surname><given-names>DN</given-names></name><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sex and Racial differences in systemic lupus erythematosus among US adults in the all of Us research program</article-title><source>Arthritis Care Res (Hoboken)</source><year>2023</year><volume>75</volume><issue>10</issue><fpage>2096</fpage><lpage>2106</lpage><pub-id pub-id-type="doi">10.1002/acr.25093</pub-id><pub-id pub-id-type="pmid">36705447</pub-id><pub-id pub-id-type="pmcid">PMC10372192</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Rice C, Ayyala DN, Shi H et al (2023) Sex and Racial differences in systemic lupus erythematosus among US adults in the all of Us research program. Arthritis Care Res (Hoboken) 75(10):2096&#8211;2106<pub-id pub-id-type="pmid">36705447</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.25093</pub-id><pub-id pub-id-type="pmcid">PMC10372192</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mac&#234;do</surname><given-names>EA</given-names></name><name name-style="western"><surname>Appenzeller</surname><given-names>S</given-names></name><name name-style="western"><surname>Costallat</surname><given-names>LTL</given-names></name></person-group><article-title>Depression in systemic lupus erythematosus: gender differences in the performance of the Beck depression inventory (BDI), center for epidemiologic studies depression scale (CES-D), and hospital anxiety and depression scale (HADS)</article-title><source>Lupus</source><year>2018</year><volume>27</volume><issue>2</issue><fpage>179</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1177/0961203317713142</pub-id><pub-id pub-id-type="pmid">28587586</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Mac&#234;do EA, Appenzeller S, Costallat LTL (2018) Depression in systemic lupus erythematosus: gender differences in the performance of the Beck depression inventory (BDI), center for epidemiologic studies depression scale (CES-D), and hospital anxiety and depression scale (HADS). Lupus 27(2):179&#8211;189<pub-id pub-id-type="pmid">28587586</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203317713142</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mac&#234;do</surname><given-names>EA</given-names></name><name name-style="western"><surname>Appenzeller</surname><given-names>S</given-names></name><name name-style="western"><surname>Lavras Costallat</surname><given-names>LT</given-names></name></person-group><article-title>Assessment of the hospital anxiety and depression scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus</article-title><source>Rheumatol Int</source><year>2017</year><volume>37</volume><issue>12</issue><fpage>1999</fpage><lpage>2004</lpage><pub-id pub-id-type="doi">10.1007/s00296-017-3819-x</pub-id><pub-id pub-id-type="pmid">28940018</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Mac&#234;do EA, Appenzeller S, Lavras Costallat LT (2017) Assessment of the hospital anxiety and depression scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus. Rheumatol Int 37(12):1999&#8211;2004<pub-id pub-id-type="pmid">28940018</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00296-017-3819-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mac&#234;do</surname><given-names>EA</given-names></name><name name-style="western"><surname>Appenzeller</surname><given-names>S</given-names></name><name name-style="western"><surname>Costallat</surname><given-names>LT</given-names></name></person-group><article-title>Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life</article-title><source>Lupus</source><year>2016</year><volume>25</volume><issue>12</issue><fpage>1315</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.1177/0961203316638934</pub-id><pub-id pub-id-type="pmid">26989166</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Mac&#234;do EA, Appenzeller S, Costallat LT (2016) Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life. Lupus 25(12):1315&#8211;1327<pub-id pub-id-type="pmid">26989166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203316638934</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blomjous</surname><given-names>BS</given-names></name><name name-style="western"><surname>Gajadin</surname><given-names>GRS</given-names></name><name name-style="western"><surname>Voskuyl</surname><given-names>AE</given-names></name><etal/></person-group><article-title>Work participation in patients with systematic lupus erythematosus: a systematic review</article-title><source>Rheumatology (Oxford)</source><year>2022</year><volume>61</volume><issue>7</issue><fpage>2740</fpage><lpage>2754</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/keab855</pub-id><pub-id pub-id-type="pmid">34792543</pub-id><pub-id pub-id-type="pmcid">PMC9258549</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Blomjous BS, Gajadin GRS, Voskuyl AE et al (2022) Work participation in patients with systematic lupus erythematosus: a systematic review. Rheumatology (Oxford) 61(7):2740&#8211;2754<pub-id pub-id-type="pmid">34792543</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rheumatology/keab855</pub-id><pub-id pub-id-type="pmcid">PMC9258549</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yelin</surname><given-names>E</given-names></name><name name-style="western"><surname>Trupin</surname><given-names>L</given-names></name><name name-style="western"><surname>Katz</surname><given-names>P</given-names></name><etal/></person-group><article-title>Work dynamics among persons with systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>2007</year><volume>57</volume><issue>1</issue><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1002/art.22481</pub-id><pub-id pub-id-type="pmid">17266065</pub-id><pub-id pub-id-type="pmcid">PMC2875125</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Yelin E, Trupin L, Katz P et al (2007) Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 57(1):56&#8211;63<pub-id pub-id-type="pmid">17266065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/art.22481</pub-id><pub-id pub-id-type="pmcid">PMC2875125</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bertoli</surname><given-names>AM</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>M</given-names></name><name name-style="western"><surname>Alarcon</surname><given-names>GS</given-names></name><name name-style="western"><surname>Vila</surname><given-names>LM</given-names></name><name name-style="western"><surname>Reveille</surname><given-names>JD</given-names></name></person-group><article-title>Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability</article-title><source>Ann Rheum Dis</source><year>2007</year><volume>66</volume><issue>1</issue><fpage>12</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1136/ard.2006.055343</pub-id><pub-id pub-id-type="pmid">16815862</pub-id><pub-id pub-id-type="pmcid">PMC1798398</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Bertoli AM, Fernandez M, Alarcon GS, Vila LM, Reveille JD (2007) Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability. Ann Rheum Dis 66(1):12&#8211;17<pub-id pub-id-type="pmid">16815862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/ard.2006.055343</pub-id><pub-id pub-id-type="pmcid">PMC1798398</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>N&#248;rgaard</surname><given-names>JC</given-names></name><name name-style="western"><surname>Stengaard-Pedersen</surname><given-names>K</given-names></name><name name-style="western"><surname>N&#248;rgaard</surname><given-names>M</given-names></name><name name-style="western"><surname>de Thurah</surname><given-names>A</given-names></name></person-group><article-title>Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark</article-title><source>Lupus</source><year>2015</year><volume>24</volume><issue>3</issue><fpage>299</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1177/0961203314555351</pub-id><pub-id pub-id-type="pmid">25318969</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">N&#248;rgaard JC, Stengaard-Pedersen K, N&#248;rgaard M, de Thurah A (2015) Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark. Lupus 24(3):299&#8211;306<pub-id pub-id-type="pmid">25318969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203314555351</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lao</surname><given-names>C</given-names></name><name name-style="western"><surname>Dantzig</surname><given-names>PV</given-names></name><name name-style="western"><surname>Tugnet</surname><given-names>N</given-names></name><name name-style="western"><surname>Lawrenson</surname><given-names>R</given-names></name><name name-style="western"><surname>White</surname><given-names>D</given-names></name></person-group><article-title>Treatment patterns in patients with systemic lupus erythematosus in new Zealand</article-title><source>Lupus</source><year>2024</year><volume>33</volume><issue>11</issue><fpage>1260</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1177/09612033241274911</pub-id><pub-id pub-id-type="pmid">39149963</pub-id><pub-id pub-id-type="pmcid">PMC11420593</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Lao C, Dantzig PV, Tugnet N, Lawrenson R, White D (2024) Treatment patterns in patients with systemic lupus erythematosus in new Zealand. Lupus 33(11):1260&#8211;1273<pub-id pub-id-type="pmid">39149963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/09612033241274911</pub-id><pub-id pub-id-type="pmcid">PMC11420593</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bethel</surname><given-names>M</given-names></name><name name-style="western"><surname>Yang</surname><given-names>FM</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Hydroxychloroquine in patients with systemic lupus erythematosus with end-stage renal disease</article-title><source>J Investig Med</source><year>2016</year><volume>64</volume><issue>4</issue><fpage>908</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1136/jim-2016-000065</pub-id><pub-id pub-id-type="pmid">26911274</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Bethel M, Yang FM, Li S et al (2016) Hydroxychloroquine in patients with systemic lupus erythematosus with end-stage renal disease. J Investig Med 64(4):908&#8211;910<pub-id pub-id-type="pmid">26911274</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jim-2016-000065</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feldman</surname><given-names>CH</given-names></name><name name-style="western"><surname>Collins</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Azathioprine and mycophenolate mofetil adherence patterns and predictors among medicaid beneficiaries with systemic lupus erythematosus</article-title><source>Arthritis Care Res (Hoboken)</source><year>2019</year><volume>71</volume><issue>11</issue><fpage>1419</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1002/acr.23792</pub-id><pub-id pub-id-type="pmid">30354025</pub-id><pub-id pub-id-type="pmcid">PMC6482109</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Feldman CH, Collins J, Zhang Z et al (2019) Azathioprine and mycophenolate mofetil adherence patterns and predictors among medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 71(11):1419&#8211;1424<pub-id pub-id-type="pmid">30354025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.23792</pub-id><pub-id pub-id-type="pmcid">PMC6482109</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feldman</surname><given-names>CH</given-names></name><name name-style="western"><surname>Collins</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Dynamic patterns and predictors of hydroxychloroquine nonadherence among medicaid beneficiaries with systemic lupus erythematosus</article-title><source>Semin Arthritis Rheum</source><year>2018</year><volume>48</volume><issue>2</issue><fpage>205</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2018.01.002</pub-id><pub-id pub-id-type="pmid">29458974</pub-id><pub-id pub-id-type="pmcid">PMC6035896</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Feldman CH, Collins J, Zhang Z et al (2018) Dynamic patterns and predictors of hydroxychloroquine nonadherence among medicaid beneficiaries with systemic lupus erythematosus. Semin Arthritis Rheum 48(2):205&#8211;213<pub-id pub-id-type="pmid">29458974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semarthrit.2018.01.002</pub-id><pub-id pub-id-type="pmcid">PMC6035896</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodziewicz</surname><given-names>M</given-names></name><name name-style="western"><surname>Dyball</surname><given-names>S</given-names></name><name name-style="western"><surname>Lunt</surname><given-names>M</given-names></name><etal/></person-group><article-title>Early infection risk in patients with systemic lupus erythematosus treated with rituximab or Belimumab from the British Isles lupus assessment group biologics register (BILAG-BR): a prospective longitudinal study</article-title><source>Lancet Rheumatol</source><year>2023</year><volume>5</volume><issue>5</issue><fpage>e284</fpage><lpage>e92</lpage><pub-id pub-id-type="doi">10.1016/S2665-9913(23)00091-7</pub-id><pub-id pub-id-type="pmid">38251591</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Rodziewicz M, Dyball S, Lunt M et al (2023) Early infection risk in patients with systemic lupus erythematosus treated with rituximab or Belimumab from the British Isles lupus assessment group biologics register (BILAG-BR): a prospective longitudinal study. Lancet Rheumatol 5(5):e284&#8211;e92<pub-id pub-id-type="pmid">38251591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2665-9913(23)00091-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palazzo</surname><given-names>L</given-names></name><name name-style="western"><surname>Lindblom</surname><given-names>J</given-names></name><name name-style="western"><surname>Cetrez</surname><given-names>N</given-names></name><name name-style="western"><surname>Ala</surname><given-names>H</given-names></name><name name-style="western"><surname>Parodis</surname><given-names>I</given-names></name></person-group><article-title>Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of Belimumab</article-title><source>Rheumatology (Oxford)</source><year>2024</year><volume>63</volume><issue>3</issue><fpage>798</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kead249</pub-id><pub-id pub-id-type="pmid">37228034</pub-id><pub-id pub-id-type="pmcid">PMC10907808</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Palazzo L, Lindblom J, Cetrez N, Ala H, Parodis I (2024) Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of Belimumab. Rheumatology (Oxford) 63(3):798&#8211;808<pub-id pub-id-type="pmid">37228034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rheumatology/kead249</pub-id><pub-id pub-id-type="pmcid">PMC10907808</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salgado</surname><given-names>E</given-names></name><name name-style="western"><surname>Romera-Baures</surname><given-names>M</given-names></name><name name-style="western"><surname>Beltran-Catalan</surname><given-names>E</given-names></name><etal/></person-group><article-title>Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review</article-title><source>Semin Arthritis Rheum</source><year>2022</year><volume>52</volume><fpage>151920</fpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2021.10.004</pub-id><pub-id pub-id-type="pmid">34872742</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Salgado E, Romera-Baures M, Beltran-Catalan E et al (2022) Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review. Semin Arthritis Rheum 52:151920<pub-id pub-id-type="pmid">34872742</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semarthrit.2021.10.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="other">Ramos SGI, Mormandi F, Nagelberg EA, Otero AJ (2020) High prevalence of altered immunological biomarkers in a transgender population. Autoimmun Infec Dis 3(1). 10.16966/2470-1025.125</mixed-citation></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanda</surname><given-names>N</given-names></name><name name-style="western"><surname>Tsuchida</surname><given-names>T</given-names></name><name name-style="western"><surname>Tamaki</surname><given-names>K</given-names></name></person-group><article-title>Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>1997</year><volume>40</volume><issue>9</issue><fpage>1703</fpage><lpage>1711</lpage><pub-id pub-id-type="doi">10.1002/art.1780400921</pub-id><pub-id pub-id-type="pmid">9324026</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Kanda N, Tsuchida T, Tamaki K (1997) Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 40(9):1703&#8211;1711<pub-id pub-id-type="pmid">9324026</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/art.1780400921</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alonso</surname><given-names>MD</given-names></name><name name-style="western"><surname>Mart&#237;nez-V&#225;zquez</surname><given-names>F</given-names></name><name name-style="western"><surname>Riancho-Zarrabeitia</surname><given-names>L</given-names></name><etal/></person-group><article-title>Sex differences in patients with systemic lupus erythematosus from Northwest Spain</article-title><source>Rheumatol Int</source><year>2014</year><volume>34</volume><issue>1</issue><fpage>11</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1007/s00296-013-2798-9</pub-id><pub-id pub-id-type="pmid">23812032</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Alonso MD, Mart&#237;nez-V&#225;zquez F, Riancho-Zarrabeitia L et al (2014) Sex differences in patients with systemic lupus erythematosus from Northwest Spain. Rheumatol Int 34(1):11&#8211;24<pub-id pub-id-type="pmid">23812032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00296-013-2798-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>D</given-names></name><name name-style="western"><surname>Ansar Ahmed</surname><given-names>S</given-names></name></person-group><article-title>The immune system is a natural target for Estrogen action: opposing effects of Estrogen in two prototypical autoimmune diseases</article-title><source>Front Immunol</source><year>2015</year><volume>6</volume><fpage>635</fpage><pub-id pub-id-type="pmid">26779182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2015.00635</pub-id><pub-id pub-id-type="pmcid">PMC4701921</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Khan D, Ansar Ahmed S (2015) The immune system is a natural target for Estrogen action: opposing effects of Estrogen in two prototypical autoimmune diseases. Front Immunol 6:635<pub-id pub-id-type="pmid">26779182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2015.00635</pub-id><pub-id pub-id-type="pmcid">PMC4701921</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cervera</surname><given-names>R</given-names></name><name name-style="western"><surname>Piette</surname><given-names>JC</given-names></name><name name-style="western"><surname>Font</surname><given-names>J</given-names></name><etal/></person-group><article-title>Antiphospholipid syndrome: clinical and Immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients</article-title><source>Arthritis Rheum</source><year>2002</year><volume>46</volume><issue>4</issue><fpage>1019</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1002/art.10187</pub-id><pub-id pub-id-type="pmid">11953980</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and Immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46(4):1019&#8211;1027<pub-id pub-id-type="pmid">11953980</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/art.10187</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moschetti</surname><given-names>L</given-names></name><name name-style="western"><surname>Dal Pozzolo</surname><given-names>L</given-names></name><name name-style="western"><surname>Le Guern</surname><given-names>V</given-names></name><etal/></person-group><article-title>Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres</article-title><source>Clin Exp Rheumatol</source><year>2022</year><volume>40</volume><issue>Suppl 134</issue><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.55563/clinexprheumatol/9royri</pub-id><pub-id pub-id-type="pmid">35349408</pub-id></element-citation><mixed-citation id="mc-CR88" publication-type="journal">Moschetti L, Dal Pozzolo L, Le Guern V et al (2022) Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres. Clin Exp Rheumatol 40(Suppl 134):19&#8211;26<pub-id pub-id-type="pmid">35349408</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.55563/clinexprheumatol/9royri</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simard</surname><given-names>JF</given-names></name><name name-style="western"><surname>Chaichian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rizk</surname><given-names>N</given-names></name><name name-style="western"><surname>Rector</surname><given-names>A</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>CH</given-names></name><name name-style="western"><surname>Falasinnu</surname><given-names>TO</given-names></name></person-group><article-title>Are we missing lupus in males?? Evidence of cognitive Bias from a randomized experiment in the united States</article-title><source>Am J Epidemiol</source><year>2022</year><volume>191</volume><issue>1</issue><fpage>230</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1093/aje/kwab199</pub-id><pub-id pub-id-type="pmid">34308469</pub-id><pub-id pub-id-type="pmcid">PMC8925022</pub-id></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Simard JF, Chaichian Y, Rizk N, Rector A, Feldman CH, Falasinnu TO (2022) Are we missing lupus in males?? Evidence of cognitive Bias from a randomized experiment in the united States. Am J Epidemiol 191(1):230&#8211;233<pub-id pub-id-type="pmid">34308469</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/kwab199</pub-id><pub-id pub-id-type="pmcid">PMC8925022</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Im</surname><given-names>CH</given-names></name><name name-style="western"><surname>Park</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JY</given-names></name><etal/></person-group><article-title>CXCR3 polymorphism is associated with male gender and pleuritis in patients with systemic lupus erythematosus</article-title><source>Hum Immunol</source><year>2014</year><volume>75</volume><issue>5</issue><fpage>466</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.humimm.2014.02.005</pub-id><pub-id pub-id-type="pmid">24530757</pub-id></element-citation><mixed-citation id="mc-CR90" publication-type="journal">Im CH, Park JA, Kim JY et al (2014) CXCR3 polymorphism is associated with male gender and pleuritis in patients with systemic lupus erythematosus. Hum Immunol 75(5):466&#8211;469<pub-id pub-id-type="pmid">24530757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.humimm.2014.02.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corker</surname><given-names>A</given-names></name><name name-style="western"><surname>Learmonth</surname><given-names>M</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>DM</given-names></name><name name-style="western"><surname>DeLeon-Pennell</surname><given-names>KY</given-names></name><name name-style="western"><surname>Van Beusecum</surname><given-names>JP</given-names></name></person-group><article-title>Cardiac and vascular complications in lupus: is there a role for sex?</article-title><source>Front Immunol</source><year>2023</year><volume>14</volume><fpage>1098383</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2023.1098383</pub-id><pub-id pub-id-type="pmid">37063843</pub-id><pub-id pub-id-type="pmcid">PMC10090292</pub-id></element-citation><mixed-citation id="mc-CR91" publication-type="journal">Corker A, Learmonth M, Patrick DM, DeLeon-Pennell KY, Van Beusecum JP (2023) Cardiac and vascular complications in lupus: is there a role for sex? Front Immunol 14:1098383<pub-id pub-id-type="pmid">37063843</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2023.1098383</pub-id><pub-id pub-id-type="pmcid">PMC10090292</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vavlukis</surname><given-names>M</given-names></name><name name-style="western"><surname>Pop-Gjorcevab</surname><given-names>D</given-names></name><name name-style="western"><surname>Poposka</surname><given-names>L</given-names></name><name name-style="western"><surname>Sandevska</surname><given-names>E</given-names></name><name name-style="western"><surname>Kedev</surname><given-names>S</given-names></name></person-group><article-title>Myocardial infarction in systemic lupus Erythematosus - the Sex-Specific risk profile</article-title><source>Curr Pharm Des</source><year>2021</year><volume>27</volume><issue>29</issue><fpage>3221</fpage><lpage>3228</lpage><pub-id pub-id-type="doi">10.2174/1381612826666201210110809</pub-id><pub-id pub-id-type="pmid">33302858</pub-id></element-citation><mixed-citation id="mc-CR92" publication-type="journal">Vavlukis M, Pop-Gjorcevab D, Poposka L, Sandevska E, Kedev S (2021) Myocardial infarction in systemic lupus Erythematosus - the Sex-Specific risk profile. Curr Pharm Des 27(29):3221&#8211;3228<pub-id pub-id-type="pmid">33302858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1381612826666201210110809</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilkinson</surname><given-names>NM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HC</given-names></name><name name-style="western"><surname>Lechner</surname><given-names>MG</given-names></name><name name-style="western"><surname>Su</surname><given-names>MA</given-names></name></person-group><article-title>Sex differences in immunity</article-title><source>Annu Rev Immunol</source><year>2022</year><volume>40</volume><fpage>75</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-101320-125133</pub-id><pub-id pub-id-type="pmid">34985929</pub-id><pub-id pub-id-type="pmcid">PMC9805670</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">Wilkinson NM, Chen HC, Lechner MG, Su MA (2022) Sex differences in immunity. Annu Rev Immunol 40:75&#8211;94<pub-id pub-id-type="pmid">34985929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-immunol-101320-125133</pub-id><pub-id pub-id-type="pmcid">PMC9805670</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrillo</surname><given-names>A</given-names></name><name name-style="western"><surname>Marengo-Rodr&#237;guez</surname><given-names>D</given-names></name><name name-style="western"><surname>Ibarra-Velasco-Siles</surname><given-names>M</given-names></name><etal/></person-group><article-title>Addressing the unspoken: sexual dysfunction in men with systemic lupus erythematosus, a call to action for rheumatologists</article-title><source>Sex Med Rev</source><year>2024</year><volume>12</volume><issue>3</issue><fpage>434</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1093/sxmrev/qeae033</pub-id><pub-id pub-id-type="pmid">38796305</pub-id></element-citation><mixed-citation id="mc-CR94" publication-type="journal">Carrillo A, Marengo-Rodr&#237;guez D, Ibarra-Velasco-Siles M et al (2024) Addressing the unspoken: sexual dysfunction in men with systemic lupus erythematosus, a call to action for rheumatologists. Sex Med Rev 12(3):434&#8211;441<pub-id pub-id-type="pmid">38796305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/sxmrev/qeae033</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merayo-Chalico</surname><given-names>J</given-names></name><name name-style="western"><surname>Barrera-Vargas</surname><given-names>A</given-names></name><name name-style="western"><surname>Morales-Padilla</surname><given-names>S</given-names></name><etal/></person-group><article-title>Epidemiologic profile of erectile dysfunction in patients with systemic lupus erythematosus: the Latin American landscape</article-title><source>J Rheumatol</source><year>2019</year><volume>46</volume><issue>4</issue><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.3899/jrheum.180292</pub-id><pub-id pub-id-type="pmid">30647184</pub-id></element-citation><mixed-citation id="mc-CR95" publication-type="journal">Merayo-Chalico J, Barrera-Vargas A, Morales-Padilla S et al (2019) Epidemiologic profile of erectile dysfunction in patients with systemic lupus erythematosus: the Latin American landscape. J Rheumatol 46(4):397&#8211;404<pub-id pub-id-type="pmid">30647184</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3899/jrheum.180292</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campos-Guzm&#225;n</surname><given-names>J</given-names></name><name name-style="western"><surname>Valdez-L&#243;pez</surname><given-names>M</given-names></name><name name-style="western"><surname>Govea-Pel&#225;ez</surname><given-names>S</given-names></name><etal/></person-group><article-title>Determinants of sexual function in male patients with systemic lupus erythematosus</article-title><source>Lupus</source><year>2022</year><volume>31</volume><issue>10</issue><fpage>1211</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1177/09612033221107802</pub-id><pub-id pub-id-type="pmid">35702930</pub-id></element-citation><mixed-citation id="mc-CR96" publication-type="journal">Campos-Guzm&#225;n J, Valdez-L&#243;pez M, Govea-Pel&#225;ez S et al (2022) Determinants of sexual function in male patients with systemic lupus erythematosus. Lupus 31(10):1211&#8211;1217<pub-id pub-id-type="pmid">35702930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/09612033221107802</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costedoat-Chalumeau</surname><given-names>N</given-names></name><name name-style="western"><surname>Pouchot</surname><given-names>J</given-names></name><name name-style="western"><surname>Guettrot-Imbert</surname><given-names>G</given-names></name><etal/></person-group><article-title>Adherence to treatment in systemic lupus erythematosus patients</article-title><source>Best Pract Res Clin Rheumatol</source><year>2013</year><volume>27</volume><issue>3</issue><fpage>329</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.berh.2013.07.001</pub-id><pub-id pub-id-type="pmid">24238690</pub-id></element-citation><mixed-citation id="mc-CR97" publication-type="journal">Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G et al (2013) Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol 27(3):329&#8211;340<pub-id pub-id-type="pmid">24238690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.berh.2013.07.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ptacek</surname><given-names>JT</given-names></name><name name-style="western"><surname>Smith</surname><given-names>RE</given-names></name><name name-style="western"><surname>Dodge</surname><given-names>KL</given-names></name></person-group><article-title>Gender differences in coping with stress: when stressor and appraisals do not differ</article-title><source>Pers Soc Psychol Bull</source><year>1994</year><volume>20</volume><fpage>421</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1177/0146167294204009</pub-id></element-citation><mixed-citation id="mc-CR98" publication-type="journal">Ptacek JT, Smith RE, Dodge KL (1994) Gender differences in coping with stress: when stressor and appraisals do not differ. Pers Soc Psychol Bull 20:421&#8211;430. 10.1177/0146167294204009</mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>SR</given-names></name><name name-style="western"><surname>Brinks</surname><given-names>R</given-names></name><name name-style="western"><surname>Costenbader</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities</article-title><source>Ann Rheum Dis</source><year>2020</year><volume>79</volume><issue>10</issue><fpage>1333</fpage><lpage>1339</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2020-217162</pub-id><pub-id pub-id-type="pmid">32816709</pub-id></element-citation><mixed-citation id="mc-CR99" publication-type="journal">Johnson SR, Brinks R, Costenbader KH et al (2020) Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis 79(10):1333&#8211;1339<pub-id pub-id-type="pmid">32816709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2020-217162</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>SR</given-names></name><name name-style="western"><surname>Diaz Martinez</surname><given-names>JP</given-names></name><name name-style="western"><surname>Whittall-Garcia</surname><given-names>L</given-names></name><name name-style="western"><surname>Urowitz</surname><given-names>MB</given-names></name><name name-style="western"><surname>Gladman</surname><given-names>DD</given-names></name><name name-style="western"><surname>Touma</surname><given-names>Z</given-names></name></person-group><article-title>Evaluating the threshold score for classification of systemic lupus erythematosus using the EULAR/ACR criteria</article-title><source>J Rheumatol</source><year>2023</year><volume>50</volume><issue>4</issue><fpage>512</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.3899/jrheum.220100</pub-id><pub-id pub-id-type="pmid">36319012</pub-id></element-citation><mixed-citation id="mc-CR100" publication-type="journal">Johnson SR, Diaz Martinez JP, Whittall-Garcia L, Urowitz MB, Gladman DD, Touma Z (2023) Evaluating the threshold score for classification of systemic lupus erythematosus using the EULAR/ACR criteria. J Rheumatol 50(4):512&#8211;518<pub-id pub-id-type="pmid">36319012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3899/jrheum.220100</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jolly</surname><given-names>M</given-names></name><name name-style="western"><surname>Pickard</surname><given-names>AS</given-names></name><name name-style="western"><surname>Block</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Disease-specific patient reported outcome tools for systemic lupus erythematosus</article-title><source>Semin Arthritis Rheum</source><year>2012</year><volume>42</volume><issue>1</issue><fpage>56</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2011.12.005</pub-id><pub-id pub-id-type="pmid">22480408</pub-id></element-citation><mixed-citation id="mc-CR101" publication-type="journal">Jolly M, Pickard AS, Block JA et al (2012) Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum 42(1):56&#8211;65<pub-id pub-id-type="pmid">22480408</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semarthrit.2011.12.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chakravarty</surname><given-names>EF</given-names></name><name name-style="western"><surname>Utset</surname><given-names>T</given-names></name><name name-style="western"><surname>Kamen</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial</article-title><source>Lancet Rheumatol</source><year>2024</year><volume>6</volume><issue>3</issue><fpage>e168</fpage><lpage>e77</lpage><pub-id pub-id-type="doi">10.1016/S2665-9913(23)00320-X</pub-id><pub-id pub-id-type="pmid">38301682</pub-id><pub-id pub-id-type="pmcid">PMC10922882</pub-id></element-citation><mixed-citation id="mc-CR102" publication-type="journal">Chakravarty EF, Utset T, Kamen DL et al (2024) Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. Lancet Rheumatol 6(3):e168&#8211;e77<pub-id pub-id-type="pmid">38301682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2665-9913(23)00320-X</pub-id><pub-id pub-id-type="pmcid">PMC10922882</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falasinnu</surname><given-names>T</given-names></name><name name-style="western"><surname>Chaichian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bass</surname><given-names>MB</given-names></name><name name-style="western"><surname>Simard</surname><given-names>JF</given-names></name></person-group><article-title>The representation of gender and race/ethnic groups in randomized clinical trials of individuals with systemic lupus erythematosus</article-title><source>Curr Rheumatol Rep</source><year>2018</year><volume>20</volume><issue>4</issue><fpage>20</fpage><pub-id pub-id-type="doi">10.1007/s11926-018-0728-2</pub-id><pub-id pub-id-type="pmid">29550947</pub-id><pub-id pub-id-type="pmcid">PMC5857270</pub-id></element-citation><mixed-citation id="mc-CR103" publication-type="journal">Falasinnu T, Chaichian Y, Bass MB, Simard JF (2018) The representation of gender and race/ethnic groups in randomized clinical trials of individuals with systemic lupus erythematosus. Curr Rheumatol Rep 20(4):20<pub-id pub-id-type="pmid">29550947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11926-018-0728-2</pub-id><pub-id pub-id-type="pmcid">PMC5857270</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>M</given-names></name><name name-style="western"><surname>Dai</surname><given-names>L</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Serological and clinical associations of autoantibodies in Chinese patients with new-onset systemic lupus erythematosus</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><issue>1</issue><fpage>10101</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-37100-5</pub-id><pub-id pub-id-type="pmid">37344560</pub-id><pub-id pub-id-type="pmcid">PMC10284812</pub-id></element-citation><mixed-citation id="mc-CR104" publication-type="journal">Gong M, Dai L, Xie Z et al (2023) Serological and clinical associations of autoantibodies in Chinese patients with new-onset systemic lupus erythematosus. Sci Rep 13(1):10101<pub-id pub-id-type="pmid">37344560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-37100-5</pub-id><pub-id pub-id-type="pmcid">PMC10284812</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shaharir</surname><given-names>SS</given-names></name><name name-style="western"><surname>Kadir</surname><given-names>WDA</given-names></name><name name-style="western"><surname>Nordin</surname><given-names>F</given-names></name><etal/></person-group><article-title>Systemic lupus erythematosus among male patients in malaysia: how are we different from other geographical</article-title><source>regions? Lupus</source><year>2019</year><volume>28</volume><issue>1</issue><fpage>137</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1177/0961203318812676</pub-id><pub-id pub-id-type="pmid">30458692</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Shaharir SS, Kadir WDA, Nordin F et al (2019) Systemic lupus erythematosus among male patients in malaysia: how are we different from other geographical. regions? Lupus 28(1):137&#8211;144<pub-id pub-id-type="pmid">30458692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203318812676</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Hadidi</surname><given-names>KT</given-names></name><name name-style="western"><surname>Medhat</surname><given-names>BM</given-names></name><name name-style="western"><surname>Abdel Baki</surname><given-names>NM</given-names></name><etal/></person-group><article-title>Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center</article-title><source>Lupus</source><year>2018</year><volume>27</volume><issue>6</issue><fpage>1030</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1177/0961203317751856</pub-id><pub-id pub-id-type="pmid">29431056</pub-id></element-citation><mixed-citation id="mc-CR106" publication-type="journal">El Hadidi KT, Medhat BM, Abdel Baki NM et al (2018) Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center. Lupus 27(6):1030&#8211;1038<pub-id pub-id-type="pmid">29431056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203317751856</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budhoo</surname><given-names>A</given-names></name><name name-style="western"><surname>Mody</surname><given-names>GM</given-names></name><name name-style="western"><surname>Dubula</surname><given-names>T</given-names></name><name name-style="western"><surname>Patel</surname><given-names>N</given-names></name><name name-style="western"><surname>Mody</surname><given-names>PG</given-names></name></person-group><article-title>Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus</article-title><source>Lupus</source><year>2017</year><volume>26</volume><issue>4</issue><fpage>438</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1177/0961203316676380</pub-id><pub-id pub-id-type="pmid">27837197</pub-id></element-citation><mixed-citation id="mc-CR107" publication-type="journal">Budhoo A, Mody GM, Dubula T, Patel N, Mody PG (2017) Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus. Lupus 26(4):438&#8211;446<pub-id pub-id-type="pmid">27837197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0961203316676380</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rastin</surname><given-names>M</given-names></name><name name-style="western"><surname>Mahmoudi</surname><given-names>M</given-names></name><name name-style="western"><surname>Sahebari</surname><given-names>M</given-names></name><name name-style="western"><surname>Tabasi</surname><given-names>N</given-names></name></person-group><article-title>Clinical &amp; immunological characteristics in systemic lupus erythematosus patients</article-title><source>Indian J Med Res</source><year>2017</year><volume>146</volume><issue>2</issue><fpage>224</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.4103/ijmr.IJMR_1356_15</pub-id><pub-id pub-id-type="pmid">29265023</pub-id><pub-id pub-id-type="pmcid">PMC5761032</pub-id></element-citation><mixed-citation id="mc-CR108" publication-type="journal">Rastin M, Mahmoudi M, Sahebari M, Tabasi N (2017) Clinical &amp; immunological characteristics in systemic lupus erythematosus patients. Indian J Med Res 146(2):224&#8211;229<pub-id pub-id-type="pmid">29265023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/ijmr.IJMR_1356_15</pub-id><pub-id pub-id-type="pmcid">PMC5761032</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>